Absoud Ì, Lim MJ, Chong WK, et al.; UK and Ireland Childhood CNS Inflammatory Demyelination Working Croup. Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features. Mult Scier 2013; 19(1): 76-86
Rossi A. Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin N Am 2008; 18(1): 149-161, ix ix
Lim CC. Neuroimaging in postinfectious demyelination and nutritional disorders of the central nervous system. Neuroimaging Clin N Am 2011; 21(4): 843-858, viii
Tenembaum S, Chitnis T, Ness J, Hahn JS; International Pediatric MS Study Croup. Acute disseminated encephalomyelitis. Neurology 2007; 68(16, Suppl 2): S23-S36
Lucchinetti CF, Cavrilova RH, Metz I, et al. Clinical and radiographie spectrum of pathologically confirmed tumefac-tive multiple sclerosis. Brain 2008; 131 (Pt 7): 1759-1775
Saini J, Chatterjee S, Thomas B, Kesavadas C. Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Acta Radiol 2011 ; 52(10): 1159-1168
Barkovich AJ, Ferriero DM, Bass N, Boyer R. Involvement of the pontomedullary corticospinal tracts: a useful finding in the diagnosis of X-linked adrenoleukodystrophy. AJNR Am J Neuroradiol 1997; 18(1): 95-100
Dubey P, Fatemi A, Huang H, et al. Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneu-ropathy. Ann Neurol 2005; 58(5): 758-766
Eichler FS, Itoh R, Barker PB, et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 2002; 225(1): 245-252
Eichler FS, Barker PB, Cox C, et al. Proton MR spectroscopic imaging predicts lesion progression on MRi in X-linked adrenoleukodystrophy. Neurology 2002; 58(6): 901-907
Hung KL, Wang JS, Keng WT, et al. Mutational analyses on X-linked adrenoleukodystrophy reveal a novel cryptic splicing and three missense mutations in the ABCD1 gene. Pediatr Neurol 2013; 49(3): 185-190
Kim JH, Kim HJ. Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up. Radiographics 2005; 25(3): 619-631
Loes DJ, Fatemi A, Melhem ER, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003; 61(3): 369-374
Mo YH, Chen YF, Liu HM. Adrenomyeloneuropathy, a dynamic progressive disorder: brain magnetic resonance imaging of two cases. Neuroradiology 2004; 46(4): 296-300
Oz G, Tkac I, Chamas LR, et al. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology 2005; 64(3): 434 441
Schneider JFL, Il’yasov KA, Boltshauser E, et al. Diffusion tensor imaging in cases of adrenoleukodystrophy: preliminary experience as a marker for early demyelination? AJNR Am J Neuroradiol 2003; 24(5): 819-824
Sener RN. Atypical X-linked adrenoleukodystrophy: new MRI observations with FLAIR, magnetization transfer contrast, diffusion MRI, and proton spectroscopy. Magn Reson Imaging 2002:20(2):215-219
van der Knaap M, Valk J. X-linked adrenoleukodystrophy. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 176-190
Wiesinger C, Kunze M, Regelsberger G, et al. Impaired very long-chain acyl-CoA b-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J Biol Chem 2013; 288(26): 19269-19279
Mo YH, Chen YF, Liu HM. Adrenomyeloneuropathy, a dynamic progressive disorder: brain magnetic resonance imaging of two cases. Neuroradiology 2004; 46(4): 296-300
Powers JM, DeCiero DP, Cox C, et al. The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria. J Neuropathol Exp Neurol 2001; 60(5): 493-501
Cass JT, Olive MF. Neurochemical and neurostructural plasticity in alcoholism. ACS Chem Neurosci 2012; 3(7): 494-504
Geibprasert S, Gallucci M, Krings T. Alcohol-induced changes in the brain as assessed by MRI and CT. Eur Radiol 2010; 20(6): 1492-1501
Hill SY, Terwilliger R, McDermott M. White matter microstructure, alcohol exposure, and familial risk for alcohol dependence. Psychiatry Res 2013; 212(1): 43-53
Hillbom M, Saloheimo S, Fujioka S, et al. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry 2014; 85(2): 168-173
Konrad A, Vucurevic G, Lorscheider M, et al. Broad disruption of brain white matter microstructure and relationship with neuropsychological performance in male patients with severe alcohol dependence. Alcohol Alcohol 2012; 47(2): 118-126
Barkovich AJ, Messing A. Alexander disease: not just a leukodystrophy anymore. Neurology 2006; 66(4): 468—469
Bassuk AG, Joshi A, Burton BK, et al. Alexander disease with serial MRS and a new mutation in the glial fibrillary acidic protein gene. Neurology 2003; 61(7): 1014-1015
Brockmann K, Dechent P, Meins M, et al. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol 2003; 250(3): 300-306
Johnson AB, Brenner M. Alexander’s disease: clinical, pathologic, and genetic features. J Child Neurol 2003; 18(9): 625-632
Moser HW. Alexander disease: combined gene analysis and MRI clarify pathogenesis and extend phenotype. Ann Neurol 2005: 57(3): 307-308
Ni Q, Johns GS, Manepalli A, et al. Infantile Alexander’s disease: serial neuroradiology findings. J Child Neurol 2002; 17(6): 463-466
Pareyson D, Fancellu R, Mariotti C, et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain 2008; 131 (Pt 9): 2321-2331
Poloni CB, Ferey S, Haenggeli CA, et al. Alexander disease: early presence of cerebral MRI criteria. Eur J Paediatr Neurol 2009; 13(6): 556-558
Probst EN, Hagel Ñ, Weisz V, et al. Atypical focal MRI lesions in a case of juvenile Alexander’s disease. Ann Neurol 2003; 53(1): 118-120
van der Knaap MS, Ramesh V, Schiffmann R, et al. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology 2006; 66(4): 494—498
van der Knaap MS, Salomons GS, Li R, et al. Unusual variants of Alexander’s disease. Ann Neurol 2005; 57(3): 327-338
van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001; 22(3): 541-552
van der Knaap M, Valk J. Alexander disease. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 416-435
Adlard PA, Tran BA, Finkelstein DI, et al. A review of b-amyloid neuroimaging in Alzheimer’s disease. Front Neurosci 2014; 8: 327
Becker GA, Ichise M, Barthel H, et al. PET quantification of 18F-florbetaben binding to b-amyloid deposits in human brains. J Nucl Med 2013; 54(5): 723-731
Benzinger TLS. Radiologic approach to Alzheimer’s disease and other dementias: the emerging role of diffusion tensor magnetic resonance imaging. Appl Radiol 2005; 34(1): 25-33
Goto H, Ishii K, Uemura T, et al. Differential diagnosis of dementia with Lewy Bodies and Alzheimer Disease using combined MR imaging and brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol 2010; 31(4): 720-725
Karantzoulis S, Calvin JE. Distinguishing Alzheimer’s disease from other major forms of dementia. Expert Rev Neurother 2011; 11(11): 1579-1591
Nelson PT, Alafuzoff I, Bigio EH, et al. Correlation of Alzheimer disease neuropathology changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 2012; 71(5): 362-381
Sabri O, Seibyl J, Rowe C, Barthel H. Beta-amyloid imaging with florbetaben. Clin Transl Imaging 2015; 3(1): 13-26
Vallabhajosula S. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid. Semin Nucl Med 2011; 41(4): 283-299
Whitwell JL, Shiung MM, Przybelski SA, et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008; 70(7): 512-520
Foreid H, Barroso C, Evangelista T, et al. Intracerebral amyloidoma: case report and review of the literature. Clin Neuropathol 2010; 29(4): 217-222
Gallucci M, Caulo M, Splendiani A, et al. Neuroradiological findings in two cases of isolated amyloidoma of the central nervous system. Neuroradiology 2002; 44(4): 333-337
Gandhi D, Wee R, Coyal M. CT and MR imaging of intracerebral amyloidoma: case report and review of the literature. AJNR Am J Neuroradiol 2003; 24(3): 519-522
Nossek E, Bashat DB, Artzi M, et al. The role of advanced MR methods in the diagnosis of cerebral amyloidoma. Amyloid 2009; 16(2): 94-98
Ragel ÂÒ, Blumenthal DT, Browd SR, et al. Intracerebral amyloidoma can mimic high-grade glioma on magnetic resonance imaging and spectroscopy. Arch Neurol 2006; 63(6): 906-907
Tabatabai C, Baehring J, Hochberg FH. Primary amyloidoma of the brain parenchyma. Arch Neurol 2005; 62(3): 477-480
Vital A, Ellie E, Loiseau H. A 61 -year-old man with instability of gait and right hand clumsiness. Brain Pathol 2010; 20(1): 273-274
Ciccarelli Î, Behrens ÒÅ, Johansen-Berg H, et al. Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum Brain Mapp 2009; 30(2): 615-624
Charil A, Corbo M, Filippi M, et al. Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study. Amyotroph Lateral Scler2009; 10(5-6): 269-279
da Rocha AJ, Oliveira ASB, Fonseca RB, et al. Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spin-echo magnetization transfer contrast sequence. AJNR Am J Neuroradiol 2004; 25(9): 1509-1515
Iwata NK. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis]. Brain Nerve 2007; 59(10): 1053-1064
Turner MR, Agosta F, Bede P, et al. Neuroimaging in amyotrophic lateral sclerosis. Biomarkers Med 2012; 6(3): 319-337
Wang S, Poptani H, Woo JH, et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 2006; 239(3): 831-838
Faehndrich J, Weidauer S, Pilatus U, et al. Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions. Clin Neuroradiol 2011; 21(3): 123-139
Holodny Al, Makeyev S, Beattie BJ, et al. Apparent diffusion coefficient of glial neoplasms: correlation with fluorode-oxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging. AJNR Am J Neuroradiol 2010; 31(6): 1042-1048
Kleihues P, Burger PC, Rosenblum MK, et al. Anaplastic astrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cave-nee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 30-32
Alexiou CA, Panagopoulos D, Moschovi M, et al. Supratentorial extraventricular anaplastic ependymoma in a 10-year-old girl. Pediatr Neurosurg 2010; 46(6): 480-481
McLendon RE, Wiestler OD, Kros JM, et al. Anaplastic ependymoma. In: Louis DN, Ohgaki H, Wiestler OD, Cave-nee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 79-80
Reifenberger G, Kros JM, Louis DN, Collins VP. Anaplastic oligodendroglioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 60-62
von Deimling A, Reifenberger G, Kros JM, et al. Anaplastic oligoastrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 66 67
Reifenberger G, Kros JM, Louis DN, Collins VP. Anaplastic oligodendroglioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 60-62
Brusati R, Donati V, Marelli S, Ferrari M. Management of a case of arhinia. J Plast Reconstr Aesthet Surg 2009; 62(7): e206-e210
Sato D, Shimokawa O, Harada N, et al. Congenital arhinia: molecular-genetic analysis of five patients. Am J Med Genet A 2007; 143A(6): 546-552
Zhang MM, Hu YH, He W, Hu KK. Congenital arhinia: A rare case. Am J Case Rep 2014; 15: 115-118
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24(1): 35-41
Allmendinger AM, Tang ER, Lui YW, Spektor V. Imaging of stroke: Part 1. Perfusion CT - overview of imaging technique, interpretation pearls, and common pitfalls. AJR Am J Roentgenol 2012; 198(1): 52-62
Eastwood JD, Lev MH, Provenzale JM. Perfusion CT with iodinated contrast material. AJR Am J Roentgenol 2003; 180(1): 3-12
Eskey CJ, Sanelli PC. Perfusion imaging of cerebrovascular reserve. Neuroimaging Clin N Am 2005; 15(2): 367-381, xi
Grant PE, Yu D. Acute injury to the immature brain with hypoxia with or without hypoperfusion. Magn Reson Imaging Clin N Am 2006; 14(2): 271-285
Huang BY, Castillo M. Hypoxic-ischemic brain injury: imaging findings from birth to adulthood. Radiographics 2008; 28(2): 417^439, quiz 617
Kanekar SG, Zacharia T, Roller R. Imaging of stroke: Part 2, Pathophysiology at the molecular and cellular levels and corresponding imaging changes. AJR Am J Roentgenol 2012; 198(1): 63-74
Kucinski T. Unenhanced CT and acute stroke physiology. Neuroimaging Clin N Am 2005; 15(2): 397-407, xi-xii
Lee LJ, Kidwell CS, Alger J, et al. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 2000; 31(5): 1081-1089
Marks MP. Cerebral ischemia and infarction. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2009: 772-825
Ratai EM, Gonzalez RC. Magnetic resonance spectroscopy and the biochemical basis of neurologic disease. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2009:1836-1870
Shetty SK, Lev MH. CT perfusion in acute stroke. Neuroimaging Clin N Am 2005; 15(3): 481-501, ix
Wessels T, Wessels C, Ellsiepen A, et al. Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol 2006; 7(1): 35-39
Barkovich AJ. Brain and spine injuries in infancy and childhood. In: Pediatric Neuroimaging. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2005: 190-290
Husson B, Lasjaunias P. Radiological approach to disorders of arterial brain vessels associated with childhood arterial stroke - a comparison between MRA and contrast angiography. Pediatr Radiol 2004; 34(1): 10-15
Kimchi TJ, Agid R, Lee SK, Ter Brugge KG. Arterial ischemic stroke in children. Neuroimaging Clin N Am 2007; 17(2): 175-187
Aidape KD, Rosenblum MK. Astroblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 88-89
Bell JW, Osborn AC, Salzman KL, et al. Neuroradiology characteristics of astroblastoma. Neuroradiology 2007; 49(3): 203-209
Kantar M, Ertan Y, Turhan T, et al. Anaplastic astroblastoma of childhood: aggressive behavior. Childs Nerv Syst 2009: 25(9): 1125-1129
Salvati M, D’Elia A, Brogna C, et al. Cerebral astroblastoma: analysis of six cases and critical review of treatment options. J Neurooncol 2009; 93(3): 369-378
Firat AK, Karaka? HM, Firat Y, Yakinci C. Quantitative evaluation of brain involvement in ataxia telangiectasia by diffusion weighted MR imaging. Eur J Radiol 2005; 56(2): 192-196
Lin DDM, Barker PB, Lederman HM, Crawford TO. Cerebral abnormalities in adults with ataxia-telangiectasia. AJNR Am J Neuroradiol 2014; 35(1): 119-123
Tavani F, Zimmerman RA, Berry CT, et al. Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI. Neuroradiology 2003; 45(5): 315-319
Wallis U, Griffiths PD, Ritchie SJ, et al. Proton spectroscopy and imaging at 3T in ataxia-telangiectasia. AJNR Am J Neuroradiol 2007; 28(1): 79-83
Han L, Qiu Y, Xie C, et al. Atypical teratoid/rhabdoid tumors in adult patients: CT and MR imaging features. AJNR Am J Neuroradiol 2011; 32(1): 103-108
Judkins AR, Eberhart CG, Wesseling P. Atypical teratoid/ rhabdoid tumour. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 147-149
Meyers SP, Khademian ZP, Biegel JA, et al. Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes. AJNR Am J Neuroradiol 2006; 27(5): 962-971
Warmuth-Metz M, Bison B, Dannemann-Stem E, et al. CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology 2008; 50(5): 447-A52
Arsalidou Ì, Duerden EG, Taylor MJ. The centre of the brain: topographical model of motor, cognitive, affective, and somatosensory functions of the basal ganglia. Hum Brain Mapp 2013: 34(11): 3031-3054
Herrero MT, Barcia C, Navarro JM. Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst 2002; 18(8): 386-404
Telford R, Vattoth S. MR anatomy of deep brain nuclei with special reference to specific diseases and deep brain stimulation localization. Neuroradiol J 2014; 27(1): 29—43
Siva A, Saip S. The spectrum of nervous system involvement in Behcet’s syndrome and its differential diagnosis. J Neurol 2009; 256(4): 513-529
Gupta RK, Kumar S. Central nervous system tuberculosis. Neuroimaging Clin N Am 2011; 21(4): 795-814, vii-viii
Husain N, Kumar P. Pathology of tropical diseases. Neuroimaging Clin N Am 2011; 21(4): 757-775, vii
Lai PH, Hsu SS, Ding SW, et al. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surg Neurol 2007; 68(Suppl 1): S25-S36
Luthra G, Parihar A, Nath K, et al. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol 2007; 28(7): 1332-1338
Morais LT, Zanardi V de A, Faria AV. Magnetic resonance spectroscopy in the diagnosis and etiological definition of brain bacterial abscesses. Arq Neuropsiquiatr 2007; 65(4B): 1144-1148
Rath TJ, Hughes M, Arabi M, Shah GV. Imaging of cereb-ritis, encephalitis, and brain abscess. Neuroimaging Clin N Am 2012:22(4): 585-607
Satishchandra P, Sinha S. Relevance of neuroimaging in the diagnosis and management of tropical neurologic disorders. Neuroimaging Clin N Am 2011; 21(4): 737-756, vii
Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol 2009; 8(7): 643-653
Choi JC. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a genetic cause of cerebral small vessel disease. J Clin Neurol 2010; 6(1): 1-9
Choi J, Song SK, Lee JS, et al. Diversity of stroke presentation in CADASIL: study from patients harboring the predominant NOTCH3 mutation R544C. J Stroke Cerebrovasc Dis 2013; 22(2): 126-131
Federico A, Di Donato I, Bianchi S, et al. Hereditary cerebral small vessel diseases: a review. J Neurol Sci 2012; 322(1-2): 25-30
Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol 2009; 8(7): 643-653
Aiken AH, Akgun H, Tihan T, et al. Calcifying pseudoneoplasms of the neuraxis: CT, MR imaging, and histologic features. AJNR Am J Neuroradiol 2009; 30(6): 1256-1260
Hodges TR, Karikari IO, Nimjee SM, et al. Calcifying pseudoneoplasm of the cerebellopontine angle: case report. Neurosurgery 2011; 69(1, Suppl Operative): E117-E120
Mohapatra I, Manish R, Mahadevan A, et al. Calcifying pseudoneoplasm (fibro osseous lesion) of neuraxis (CAPNON) -a case report. Clin Neuropathol 2010; 29(4): 223-226
Park P, Schmidt LA, Shah GV, et al. Calcifying pseudoneoplasm of the spine. Clin Neurol Neurosurg 2008; 110(4): 392-395
Shrier DA, Melville D, Millet D, et al. Fibro-osseous lesions involving the brain: MRI. Neuroradiology 1999; 41(1): 18-21
Bekiesinska-Figatowska M, Mierzewska H, Jurkiewicz E. Basal ganglia lesions in children and adults. Eur J Radiol 2013; 82(5): 837-849
Cakmakci H, Pekcevik Y, Yis U, et al. Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature. Eur J Radiol 2010; 74(3): e 161—e171
Leone P, Shera D, McPhee SWJ, et al. Long-term follow-up after gene therapy for Canavan disease. Sci Transl Med 2012; 4(165): 165-163
Michel SJ, Given CA 11. Case 99: Canavan disease. Radiology 2006; 241(1): 310-314
Srikanth SG, Chandrashekar HS, Nagarajan K, Jayakumar PN. Restricted diffusion in Canavan disease. Childs Nerv Syst 2007; 23(4): 465^168
van der Knaap M, Valk J. Canavan disease. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 326-333
Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. J Stroke Cerebrovasc Dis 2011; 20(2): 85-93
Lo CP, Chen SY, Lee KW, et al. Brain injury after acute carbon monoxide poisoning: early and late complications. AJR Am J Roentgenol 2007; 189(4): W205-11
Gonzalez LF, Lekovic CP, Eschbacher J, et al. Are cavernous sinus hemangiomas and cavernous malformations different entities? Neurosurg Focus 2006; 21(1): e6
Tannouri F, Divano L, Caucheteur V, et al. Cavernous haemangioma in the cavernous sinus: case report and review of the literature. Neuroradiology 2001; 43(4): 317-320
Wang X, Liu X, Mei C, et al. Phase II study to assess the efficacy of hypofractionated stereotactic radiotherapy in patients with large cavernous sinus hemangiomas. Int J Radiat Oncol Biol Phys 2012; 83(2): e223-e230
Figarella-Branger D, Soylemezoglu F, Burger PC. Central neurocytoma and extraventricular neurocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 106-109
Jaiswal S, Vij M, Rajput D, et al. A clinicopathological, immunohistochemical and neuroradiological study of eight patients with central neurocytoma. J Clin Neurosci 2011; 18(3): 334-339
Kocaoglu M, Ors F, Bulakbasi N, et al. Central neurocytoma: proton MR spectroscopy and diffusion weighted MR imaging findings. Magn Reson Imaging 2009; 27(3): 434^140
Peltier J, Baroncini M, Le Cars D, Lejeune JP. [Central neurocytomas of the lateral ventricle. A series of 35 cases with review of the literature]. Neurochirurgie 2011; 57(4-6): 215-219
Shah T, Jayasundar R, Singh VP, Sarkar C. MRS characterization of central neurocytomas using glycine. NMR Biomed 2011; 24(10): 1408-1413
Yang CF, Wu SY, Zhang LJ, et al. Imaging findings of extraventricular neurocytoma: report of 3 cases and review of the literature. AJNR Am J Neuroradiol 2009; 30(3): 581-585
Yeh IB, Xu M, Ng WH, et al. Central neurocytoma: typical magnetic resonance spectroscopy findings and atypical ventricular dissemination. Magn Reson Imaging 2008; 26(1): 59-64
Guzman-De-Villoria JA, Ferreiro-Argiielles C, Femandez-Carcia P. Differential diagnosis of T2 hyperintense brainstem lesions: Part 2. Diffuse lesions. Semin Ultrasound CT MR 2010; 31(3): 260-274
Ranger AM, Chaudhary N, Avery M, Fraser D. Central pontine and extrapontine myelinolysis in children: a review of 76 patients. J Child Neurol 2012; 27(8): 1027-1037
Poretti A, Wolf N1, Boltshauser E. Differential diagnosis of cerebellar atrophy in childhood. Eur J Paediatr Neurol 2008; 12(3): 155-167
De Bruecker Y, Claus F, Demaerel P, et al. MRI findings in acute cerebellitis. Eur Radiol 2004; 14(8): 1478-1483
Takanashi J, Miyamoto T, Ando N, et al. Clinical and radiological features of rotavirus cerebellitis. AJNR Am J Neuroradiol 2010; 31(9): 1591-1595
Barkovich AJ, Cuerrini R, Kuzniecky RI, et al. A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012; 135(Pt 5): 1348-1369
Raybaud C, Widjaja E. Development and dysgenesis of the cerebral cortex: malformations of cortical development. Neuroimaging Clin N Am 2011; 21(3): 483-543, vii
Widjaja E, Geibprasert S, Mahmoodabadi SZ, et al. Corroboration of normal and abnormal fetal cerebral lamination on postmortem MR imaging with postmortem examination. AJNR Am J Neuroradiol 2010; 31(10): 1987-1993
Gasparetto EL, Cabral RF, da Cruz LC Jr, Domingues RC. Diffusion imaging in brain infections. Neuroimaging Clin N Am 2011; 21(1): 89-113, viii
Chiapparini L, Saletti V, Solera CL, et al. Neuroradiological diagnosis of Chiari malformations. Neurol Sci 2011; 32(Suppl 3): S283-S286
Di Rocco C, Frassanito P, Massimi L, Peraio S. Hydrocephalus and Chiari type I malformation. Childs Nerv Syst 2011; 27(10): 1653-1664
McVige JW, Leonardo J. Imaging of Chiari type I malformation and syringohydromyelia. Neurol Clin 2014; 32(1): 95-126
Duprez TP, Sindic CJM. Contrast-enhanced magnetic resonance imaging and perfusion-weighted imaging for monitoring features in severe CLIPPERS. Brain 2011; 134(Pt 8): el84, author reply el86
Jones JL, Dean AF, Antoun N, et al. «Radiologically compatible CLIPPERS» may conceal a number of pathologies. Brain 2011; 134(Pt8): el87
Kastrup O, van de Nes J, Gasser T, Keyvani K. Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study. J Neurol 2011 ; 258(12): 2140-2146
Limousin N, Praline J, Motica O, et al. Brain biopsy is required in steroid-resistant patients with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). J Neurooncol 2012; 107(1): 223-224
Sempere AP, Mola S, Martin-Medina P, et al. Response to immunotherapy in CLIPPERS: clinical, MRI, and MRS follow-up. J Neuroimaging 2013; 23(2): 254-255
Simon NC, Parratt JD, Barnett MH, et al. Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). J Neurol Neurosurg Psychiatry 2012; 83( 1 ): 15-22
Taieb G, Duflos C, Renard D, et al. Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients. Arch Neurol 2012; 69(7): 847-855
Bloom J, Upton J III. CLOVES syndrome. J Hand Surg Am 2013; 38(12): 2508-2512
Gucev ZS, Tasic V, Jancevska A, et al. Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) syndrome: CNS malformations and seizures may be a component of this disorder. Am J Med Genet A 2008; 146A(20): 2688-2690
Mirzaa G, Conway R, Graham JM, Dobyns WB. PIK3CA-related segmental overgrowth. In: Paragon RA, Adam MP, Ardinger HH, et al, eds. GeneReviews. Seattle, WA: University of Washington, 2013: Aug 15
Koob M, Laugel V, Durand M, et al. Neuroimaging in Cockayne syndrome. AJNR Am J Neuroradiol 2010; 31(9): 1623-1630
van der Knaap Ì, Valk J. Cockayne syndrome. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 259-267
Weidenheim KM, Dickson DW, Rapin 1. Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration. Meeh Ageing Dev 2009; 130(9): 619-636
Lamperti C, Naini A, Hirano M, et al. Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 2003; 60(7): 1206-1208
Musumeci O, Naini A, Slonim AE, et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 2001; 56(7): 849-855
Salviati L, Sacconi S, Murer L, et al. Infantile encephalomyopathy and nephropathy with CoQlO deficiency: a CoQ10-responsive condition. Neurology 2005; 65(4): 606-608
Akin L, Kendirci Ì, Doganay S, et al. Pituitary duplication: a rare cause of precocious puberty. Childs Nerv Syst 2011; 27(7): 1157-1160
Delman BN. Imaging of pediatric pituitary abnormalities. Endocrinol Metab Clin North Am 2009; 38(4): 673-698
Hamilton BE, Salzman KL, Osborn AG. Anatomic and pathologic spectrum of pituitary infundibulum lesions. AJR Am J Roentgenol 2007; 188(3): W223-32
Di lorgi N, Allegri AEM, Napoli F, et al. The use of neuroimaging for assessing disorders of pituitary development. Clin Endocrinol (Oxf) 2012; 76(2): 161-176
de Penna GC, Pimenta MP, Drummond JB, et al. Duplication of the hypophysis associated with precocious puberty: presentation of two cases and review of pituitary embryogenesis. Arq Bras Endocrinol Metabol 2005; 49(2): 323-327
Shields R, Mangla R, Almast J, Meyers S. Magnetic resonance imaging of sellar and juxtasellar abnormalities in the paediatric population: an imaging review. Insights Imaging 2015; 6(2): 241-260
Spampinato MV, Castillo M. Congenital pathology of the pituitary gland and parasellar region. Top Magn Reson Imaging 2005; 16(4): 269-276
Barkovich AJ, Cuerrini R, Kuzniecky RI, et al. A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012; 135(Pt 5): 1348-1369
Barkovich AJ, Raybaud C. Congenital malformation of the brain and skull. In: Barkovich AJ, Raybaud C, eds. Pediatric Neuroimaging. 5th ed. New York, NY: Wolters-Kluwer/Lip-pincott Williams & Wilkins, 2012: 367-568
Guerrini R, Dobyns WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol 2014; 13(7): 710-726
Nunez S, Mantilla MT, Bermudez S. Midline congenital malformations of the brain and skull. Neuroimaging Clin N Am 2011; 21(3): 429-482, vii
Huang BY, Castillo Ì. Hypoxic-ischemic brain injury: imaging findings from birth to adulthood. Radiographics 2008; 28(2): 417-439. quiz 617
Kinoshita T, Ogawa T, Yoshida Y, et al. Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction. Neuroradiology 2005; 47(9): 647-651
Komiyama M, Nakajima H, Nishikawa M, Yasui T. Serial MR observation of cortical laminar necrosis caused by brain infarction. Neuroradiology 1998: 40(12): 771-777
Kucinski T. Unenhanced CT and acute stroke physiology. Neuroimaging Clin N Am 2005; 15(2): 397 407, xi-xii
McKinney AM, Teksam M, Felice R, et al. Diffusion-weighted imaging in the setting of diffuse cortical laminar necrosis and hypoxic-ischemic encephalopathy. AJNR Am JNeuroradiol 2004; 25(10): 1659-1665
Siskas N, Lefkopoulos A, loannidis I, et al. Cortical laminar necrosis in brain infarcts: serial MRI. Neuroradiology 2003; 45(5): 283-288
Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80(5): 496-503
Dickson DW, Bergeron C, Chin SS, et al; Office of Rare Diseases of the National Institutes of Health. Office of Rare Diseases neuropathology criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002: 61(11): 935-946
Whitwell JU, Jack CR Jr, Boeve BF, et al. Imaging correlates of pathology in corticobasal syndrome. Neurology 2010; 75(21): 1879-1887
Chen CJ. Suprasellar and infrasellar craniopharyngioma with a persistent craniopharyngeal canal: case report and review of the literature. Neuroradiology 2001; 43(9): 760-762
Kaushik C, Ramakrishnaiah R, Angtuaco EJ. Ectopic pituitary adenoma in persistent craniopharyngeal canal: case report and literature review. J Comput Assist Tomogr 2010; 34(4): 612-614
Curran JG, O’Connor E. Imaging of craniopharyngioma. Childs Nerv Syst 2005; 21 (8-9): 635-639
Rushing EJ, Giangaspero F, Paulus W, Burger PC. Craniopharyngioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 238-240
Zada G, Lin N, Ojerholm E, et al. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus 2010; 28(4): E4
Cianfoni A, Luigetti M, Bradshaw ML, et al. MRI findings of crossed cerebellar diaschisis in a case of Rasmussen’s encephalitis. J Neurol 2010; 257(10): 1748-1750
Lin DDM, Kleinman JT, Wityk RJ, et al. Crossed cerebellar diaschisis in acute stroke detected by dynamic susceptibility contrast MR perfusion imaging. AJNR Am J Neuroradiol 2009; 30(4): 710-715
Liu Y, Karonen JO, Nuutinen J, et al. Crossed cerebellar diaschisis in acute ischemic stroke: a study with serial SPECT and MRI. J Cereb Blood Flow Metab 2007; 27(10): 1724-1732
Miller NG, Reddick WE, Kocak M, et al. Cerebellocerebral diaschisis is the likely mechanism of postsurgical posterior fossa syndrome in pediatric patients with midline cerebellar tumors. AJNR Am J Neuroradiol 2010; 31(2): 288-294
Samaniego EA, Stuckert E, Fischbein N, Wijman CAC. Crossed cerebellar diaschisis in status epilepticus. Neurocrit Care 2010; 12(1): 88 90
Tien RD, Ashdown BC. Crossed cerebellar diaschisis and crossed cerebellar atrophy: correlation of MR findings, clinical symptoms, and supratentorial diseases in 26 patients. AJR Am J Roentgenol 1992; 158(5): 1155-1159
Rachinger J, Fellner FA, Stieglbauer K, Trenkler J. MR changes after acute cyanide intoxication. AJNR Am J Neuroradiol 2002; 23(8): 1398-1401
Kantarci Ê. Magnetic resonance spectroscopy in common dementias. Neuroimaging Clin N Am 2013; 23(3): 393-406
Kantarci K, Ferman TJ, Boeve BF, et al. Focal atrophy on MRi and neuropathologic classification of dementia with Lewy bodies. Neurology 2012; 79(6): 553-560
Taylor JP, O’Brien J. Neuroimaging of dementia with Lewy bodies. Neuroimaging Clin N Am 2012; 22(1): 67-81, viii
Borja MJ, Plaza MJ, Altman N, Saigal G. Conventional and advanced MRI features of pediatric intracranial tumors: supratentorial tumors. AJR Am J Roentgenol 2013; 200(5): W483-503
Brat DJ, VandenBerg SR, Figarella-Branger D, Taratuto AL. Desmoplastic infantile astrocytoma and ganglioglioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: I ARC Press, 2007: 96-98
Tamburrini G, Colosimo C Jr, Giangaspero F, et al. Desmoplastic infantile ganglioglioma. Childs Nerv Syst 2003; 19(5-6): 292-297
Trehan G, Bruge H, Vinchon M, et al. MR imaging in the diagnosis of desmoplastic infantile tumor: retrospective study of six cases. AJNR Am J Neuroradiol 2004; 25(6): 1028-1033
Anzalone N, Scotti R, Riva R. Neuroradiology differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci 2004; 25(Suppl 1): S3-S5
Hijaz TA, Cento EA, Walker MT. Imaging of head trauma. Radiol Clin North Am 2011; 49(1): 81-103
Kubal WS. Updated imaging of traumatic brain injury. Radiol Clin North Am 2012; 50(1): 15^11
Parizel PM, Makkat S, Van Miert E, et al. Intracranial hemorrhage: principles of CT and MRI interpretation. Eur Radiol 2001; 11(9): 1770-1783
Tong KA, Ashwal S, Obenaus A, et al. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008; 29(1): 9-17
Atalar MH, Icagasioglu D, Tas F. Cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome) in childhood: clinicoradiological analysis of 19 cases. Pediatr Int 2007; 49(1): 70-75
Tasdemir HA, Incesu L, Yazicioglu AK, et al. Dyke-Davidoff-Masson syndrome. Clin Imaging 2002; 26(1): 13-17
Bulakbasi N, Kocaoglu M, Sanai TH, Tayfun C. Dysem-bryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics. Neuroradiology 2007; 49(10): 805-812
Campos AR, Clusmann H, von Lehe M, et al. Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants: clinical profile, MRI, and histopathology. Neuroradiology 2009; 51(7): 433 443
Daumas-Duport C, Pietsch T, Hawkins C, Shankar SK. Dysembryoplastic neuroepithelial tumour. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: [ARC Press, 2007: 99-102
Fernandez C, Girard N, Paz Paredes A, et al. The usefulness of MR imaging in the diagnosis of dysembryoplastic neuroepithelial tumor in children: a study of 14 cases. AJNR Am J Neuroradiol 2003; 24(5): 829-834
Ozlen F, Gunduz A, Asan Z, et al. Dysembryoplastic neuroepithelial tumors and gangliogliomas: clinical results of 52 patients. Acta Neurochir (Wien) 2010; 152(10): 1661 — 1671
Parmar HA, Hawkins C, Ozelame R, et al. Fluid-attenuated inversion recovery ring sign as a marker of dysembryoplastic neuroepithelial tumors. J Comput Assist Tomogr 2007; 31(3): 348-353
Thom M, Toma A, An S, et al. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol 2011; 70(10): 859-878
Yu AH, Chen L, Li YJ, et al. Dysembryoplastic neuroepithelial tumors: magnetic resonance imaging and magnetic resonance spectroscopy evaluation. Chin Med J (Engl) 2009; 122(20): 2433-2437
Eberhart CG, Wiestler OD, Eng C. Cowden disease and dys-plastic gangliocytoma of the cerebellum/Lhermitte-Duclos disease. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007:226-228
Kumar R, Vaid VK, Kalra SK. Lhermitte-Duclos disease. Childs Nerv Syst 2007; 23(7): 729-732
Shinagare AB, Patil NK, Sorte SZ. Case 144: Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease). Radiology 2009; 251(1): 298-303
Yagci-Kiipeli B, Oguz KK, Bilen MA, et al. An unusual cause of posterior fossa mass: Lhermitte-Duclos disease. J Neurol Sci 2010; 290(1-2): 138-141
Ali M, Safriel Y, Sohi J, et al. West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol 2005; 26(2): 289-297
Bag ÀÊ, Cure JK, Chapman PR, et al. JC virus infection of the brain. AJNR Am J Neuroradiol 2010; 31(9): 1564-1576
Buckle C, Castillo M. Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience. AJNR Am J Neuroradiol 2010; 31 (6): 1031-1035
Debiasi RL, Tyler KL. West Nile virus meningoencephalitis. Nat Clin Pract Neurol 2006; 2(5): 264-275
Gupta RK, Soni N, Kumar S, Khandelwal N. Imaging of central nervous system viral diseases. J Magn Reson Imaging 2012; 35(3): 477-491
Handique SK. Viral infections of the central nervous system. Neuroimaging Clin N Am 2011; 21(4): 777-794, vii
Petropoulou KA, Gordon SM, Prayson RA, Ruggierri PM. West Nile virus meningoencephalitis: MR imaging findings. AJNR Am J Neuroradiol 2005; 26(8): 1986-1995
Sahraian MA, Radue EW, Eshaghi A, et al. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol 2012; 19(8): 1060-1069
Sureka J, Jakkani RK. Clinico-radiological spectrum of bilateral temporal lobe hyperintensity: a retrospective review. Br J Radiol 2012; 85(1017): e782-e792
McLendon RE, Rosenblum MK, Schiffer D, Wiestler OD. Myxopapillary ependymoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 72-73
McLendon RE, Wiestler OD, Kros JM, et al. Ependymoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 74-78
Yuh EL, Barkovich AJ, Gupta N. Imaging of ependymomas: MRI and CT. Childs Nerv Syst 2009; 25(10): 1203-1213
Ginsberg L, Manara R, Valentine AR, et al. Magnetic resonance imaging changes in Fabry disease. Acta Paediatr Suppl 2006; 95(451): 57-62
Viana-Baptista M. Stroke and Fabry disease. J Neurol 2012; 259(6): 1019-1028
Henkelman RM, Watts JF, Kucharczyk W. High signal intensity in MR images of calcified brain tissue. Radiology 1991; 179(1): 199-206
Oliveira JRM, Spiteri E, Sobrido MJ, et al. Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology 2004; 63(11): 2165-2167
Glenn ÎÀ, Barkovich AJ. Magnetic resonance imaging of the fetal brain and spine: an increasingly important tool in prenatal diagnosis, part 1. AJNR Am J Neuroradiol 2006; 27(8): 1604-1611
Glenn OA, Barkovich J. Magnetic resonance imaging of the fetal brain and spine: an increasingly important tool in prenatal diagnosis: part 2. AJNR Am J Neuroradiol 2006; 27(9): 1807-1814
Brobeck BR, Grant PE. Pediatric stroke: the child is not merely a small adult. Neuroimaging Clin N Am 2005; 15(3): 589-607, xi
Miller SP. Newborn brain injury: looking back to the fetus. Ann Neurol 2007; 61(4): 285-287
Hallahan BP, Craig MC, Toal F, et al. In vivo brain anatomy of adult males with Fragile X syndrome: an MRI study. Neuroimage 2011; 54(1): 16-24
Pagani E, Cinestroni A, Delia Nave R, et al. Assessment of brain white matter fiber bundle atrophy in patients with Friedreich ataxia. Radiology 2010; 255(3): 882-889
Rizzo G, Tonon C, Valentino ML, et al. Brain diffusion-weighted imaging in Friedreich’s ataxia. Mov Disord 2011; 26(4): 705-712
Josephs KA, Hodges JR, Snowden JS, et al. Neuropathologi-cal background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 2011; 122(2): 137-153
Mackenzie IRA, Neumann M, Baborie A, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011; 122(1): 111-113
Rohrer JD, Lashley T, Schott JM, et al. Clinical and neuro-anatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011; 134(Pt9): 2565-2581
Whitwell JL, Josephs KA. Neuroimaging in frontotemporal lobar degeneration - predicting molecular pathology. Nat Rev Neurol 2011; 8(3): 131-142
Mathur M, Johnson CE, Sze C. Fungal infections of the central nervous system. Neuroimaging Clin N Am 2012; 22(4): 609-632
Patiroglu T, Unal E, Karakukcu M, et al. Multiple fungal brain abscesses in a child with acute lymphoblastic leukemia. Mycopathologia 2012; 174(5-6): 505-509
Becker AJ, Wiestler OD, Figarella-Branger D, Bliimcke I. Ganglioglioma and gangliocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 103-105
Castillo M, Davis PC, Takei Y, Hoffman JC Jr. Intracranial ganglioglioma: MR, CT, and clinical findings in 18 patients. AJNR Am J Neuroradiol 1990; 11(1): 109-114
DeMarchi R, Abu-Abed S, Munoz D, Loch Macdonald R. Malignant ganglioglioma: case report and review of literature. J Neurooncol 2011; 101(2): 311-318
Lagares A, Gomez PA, Lobato RD, et al. Ganglioglioma of the brainstem: report of three cases and review of the literature. Surg Neurol 2001; 56(5): 315-322, discussion 322-324
Lobel U, Ellison DW, Shulkin BL, Patay Z. Infiltrative cerebellar ganglioglioma: conventional and advanced MRI, proton MR spectroscopic, and FDG PET findings in an 18-month-old child. Clin Radiol 2011; 66(2): 194-201
Milligan BD, Giannini C, Link MJ. Ganglioglioma in the cerebellopontine angle in a child. Case report and review of the literature. J Neurosurg 2007; 107(4, Suppl): 292-296
Safavi-Abbasi S, Di Rocco F, Chantra Ê, et al. Posterior cranial fossa gangliogliomas. Skull Base 2007; 17(4): 253-264
van der Knaap M, Valk J. GM2, gangliosidosis. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 103-111
Rosenblum MK, Nakazato Y, Matsutani M. CNS Germ cell tumours. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 198-204
Belden CJ, Valdes PA, Ran C, et al. Genetics of glioblastoma: a window into its imaging and histopathologic variability. Radiographics 2011; 31 (6): 1717-1740
Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006; 58(3): 394-403
Kleihues P, Burger PC, Aidape KD, et al. Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 33—49
Zipp L, Schwartz KM, Hewer E, et al. Magnetic resonance imaging and computed tomography findings in pediatric giant cell glioblastoma. Clin Neuroradiol 2012; 22(4): 359-363
Desclee P, Rommel D, Hemalsteen D, et al. Gliomatosis cerebri, imaging findings of 12 cases. J Neuroradiol 2010; 37(3): 148-158
Fuller GN, Kros JM. Gliomatosis cerebri. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 50-52
Guzman-de-Villoria JA, Sanchez-Gonzalez J, Munoz L, et al. 1H MR spectroscopy in the assessment of gliomatosis cerebri. AJR Am J Roentgenol 2007; 188(3): 710-714
Yu A, Li K, Li H. Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri. Eur J Radiol 2006; 59(2): 216-221
Han SJ, Yang I, Ahn BJ, et al. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer 2010; 116(5): 1358-1366
Kleihues P, Burger PC, Aidape KD, et al. Gliosarcoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 48-49
Zhang BY, Chen H, Geng DY, et al. Computed tomography and magnetic resonance features of gliosarcoma: a study of 54 cases. J Comput Assist Tomogr 2011; 35(6): 667-673
Beslow LA, Schwartz ES, Bonnemann CG. Thickening and enhancement of multiple cranial nerves in conjunction with cystic white matter lesions in early infantile Krabbe disease. Pediatr Radiol 2008; 38(6): 694-696
Brockmann K, Dechent P, Wilken B, et al. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease. Neurology 2003; 60(5): 819-825
Guo AC, Petrella JR, Kurtzberg J, Provenzale JM. Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience. Radiology 2001; 218(3): 809-815
Loes DJ, Peters C, Krivit W. Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. AJNR Am J Neuroradiol 1999; 20(2): 316-323
Patel B, Gimi B, Vachha B, et al. Optic nerve and chiasm enlargement in a case of infantile Krabbe disease: quantitative comparison with 26 age-matched controls. Pediatr Radiol 2008; 38(6): 697-699
van der Knaap M, Valk J. Globoid cell leukodystrophy: Krabbe disease. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 87-95
Elster AW. Glutaric aciduria type I: value of diffusion-weighted magnetic resonance imaging for diagnosing acute striatal necrosis. J Comput Assist Tomogr 2004; 28(1): 98-100
Hedlund GU, Longo N, Pasquali M. Glutaric acidemia type 1. Am J Med Genet C Semin Med Genet 2006; 142C(2): 86-94
Mellerio C, Marignier S, Roth P, et al. Prenatal cerebral ultrasound and MRI findings in glutaric aciduria Type 1: a de novo case. Ultrasound Obstet Gynecol 2008; 31(6): 712-714
Neumaier-Probst E, Halting I, Seitz A, et al. Neuroradio-logical findings in glutaric aciduria type 1 (glutaryl-CoA dehydrogenase deficiency). J Inherit Metab Dis 2004; 27(6): 869-876
Oguz KK, Ozturk A, Cila A. Diffusion-weighted MR imaging and MR spectroscopy in glutaric aciduria type 1. Neuroradiology 2005; 47(3): 229-234
Santos CC, Roach ES. Glutaric aciduria type I: a neuroimaging diagnosis? J Child Neurol 2005; 20(7): 588-590
Twomey EL, Naughten ER, Donoghue VB, Ryan S. Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 2003; 33(12): 823-830
Mumtaz ÍÀ, Gupta V, Singh P, et al. MR imaging findings of glutaric aciduria type II. Singapore Med J 2010; 51(4): e69-e71
Takanashi J, Fujii K, Sugita K, Kohno Y. Neuroradiologic findings in glutaric aciduria type II. Pediatr Neurol 1999; 20(2): 142-145
Koelfen W, Freund M, Jaschke W, et al. GM-2 gangliosidosis (Sandhoff’s disease): two year follow-up by MRI. Neuroradiology 1994; 36(2): 152-154
Cohen-Gadol AA, Pichelmann MA, Link MJ, et al. Granular cell tumor of the sellar and suprasellar region: clinicopatho-logic study of 11 cases and literature review. Mayo Clin Proc 2003; 78(5): 567-573
Fuller GN, Wesseling Ð. Granular cell tumour of the neurohypophysis. In: Louis DN, Ohgaki H, Wiestler OD, Cave-nee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: I ARC Press, 2007: 241-242
Wilkinson MD, Fulham MJ, Besser M. Neuroimaging findings in a suprasellar granular cell tumor. J Comput Assist Tomogr 2003;27(l): 26-29
Aidape KD, Plate KH, Vortmeyer AO, et al. Hemangioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007:184-186
Plate KH, Vortmeyer AO, Zagzag D, Neumann HPH. Von Hippel-Lindau disease and haemangioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 215-217
Torreggiani WC, Keogh C, Al-Ismail K, et al. Von Hippel-Lindau disease: a radiological essay. Clin Radiol 2002; 57(8): 670-680
Mirzaa GM, Poduri A. Megalencephaly and hemimegalen-cephaly: breakthroughs in molecular etiology. Am J Med Genet C Semin Med Genet 2014; 166C(2): 156-172
Santos AC, Escorsi-Rosset S, Simao GN, et al. Hemispheric dysplasia and hemimegalencephaly: imaging definitions. Childs Nerv Syst 2014; 30( 11): 1813-1821
Deiva Ê, Mahlaoui N, Beaudonnet F, et al. CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology 2012; 78(15): 1150-1156
Guandalini M, Butler A, Mandelstam S. Spectrum of imaging appearances in Australian children with central nervous system hemophagocytic lymphohistiocytosis. J Clin Neurosci 2014;21(2): 305-310
Jovanovic A, Kuzmanovic M, Kravljanac R, et al. Central nervous system involvement in hemophagocytic lymphohistiocytosis: a single-center experience. Pediatr Neurol 2014; 50(3): 233-237
Anzalone N, Scotti R, Riva R. Neuroradiology differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci 2004; 25(Suppl 1): S3-S5
Dainer HM, Smirniotopoulos JG. Neuroimaging of hemorrhage and vascular malformations. Semin Neurol 2008; 28(4): 533-547
Kubal WS. Updated imaging of traumatic brain injury. Radiol Clin North Am 2012; 50(1): 15-41
Leblanc GG, Golanov E, Awad I A, Young WL; Biology of Vascular Malformations of the Brain NINDS Workshop Collaborators. Biology of vascular malformations of the brain. Stroke 2009; 40(12): e694-e702
Parizel PM, Makkat S, Van Miert E, et al. Intracranial hemorrhage: principles of CT and MRi interpretation. Eur Radiol 2001; 11(9): 1770-1783
Riant F, Cecillon M, Saugier-Veber P, Toumier-Lasserve E. CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions. Neurogenetics 2013; 14(2): 133-141
Smith ÅÅ, Rosand J, Greenberg SM. Hemorrhagic stroke. Neuroimaging Clin N Am 2005; 15(2): 259-272, ix
Bindu PS, Sinha S, Taly AB, et al. Cranial MRI in acute hyperammonemic encephalopathy. Pediatr Neurol 2009; 41(2): 139-142
Rovira A, Alonso J, Cordoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 2008; 29(9): 1612-1621
Sharma P, Eesa M, Scott JN. Toxic and acquired metabolic encephalopathies: MRI appearance. AJR Am J Roentgenol 2009; 193(3): 879-886
Bartlett E, Mikulis DJ. Chasing «chasing the dragon» with MRI: leukoencephalopathy in drug abuse. Br J Radiol 2005; 78(935): 997-1004
Geibprasert S, Gallucci M, Krings T. Addictive illegal drugs: structural neuroimaging. AJNR Am J Neuroradiol 2010; 31(5): 803-808
Offiah C, Hall E. Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy. Clin Radiol 2008; 63(2): 146-152
Tamrazi B, Almast J. Your brain on drugs: imaging of drug-related changes in the central nervous system. Radiographics 2012; 32(3): 701-719
Donald KA, Walker KG, Kilborn T, et al. HIV Encephalopathy: pediatric case series description and insights from the clinic coalface. AIDS Res Ther 2015; 12(1): 2
Masters MC, Ances BM. Role of neuroimaging in HIV-associated neurocognitive disorders. Semin Neurol 2014; 34(1): 89-102
Miller RF, Isaacson PC, Hall-Craggs M, et al. Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 2004; 108(1): 17-23
Senocak E, Oguz KK, Ozgen B, et al. Imaging features of CNS involvement in AIDS. Diagn Interv Radiol 2010; 16(3): 193-200
Sibtain NA, Chinn RJS. Imaging of the central nervous system in HIV infection. Imaging 2002; 14: 48-59
Tucker KA, Robertson KR, Lin W, et al. Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol 2004; 157(1-2): 153-162
Duishanbai S, Jiafu D, Guo H, et al. Intracranial hydatid cyst in children: report of 30 cases. Childs Nerv Syst 2010; 26(6): 821-827
El-Shamam O, Amer T, El-Atta MA. Magnetic resonance imaging of simple and infected hydatid cysts of the brain. Magn Reson Imaging 2001; 19(7): 965-974
Ghonge NP, Rajan S, Aggarwal B, Sahu AK. Imaging of ruptured endocyst in an isolated intramuscular hydatid cyst -the Scroll appearance. J Radiol Case Rep 2012; 6(8): 17-21
Rumboldt Z, Jednacak H, Talan-Hranilovic J, et al. Unusual appearance of a cisternal hydatid cyst. AJNR Am J Neuroradiol 2003; 24(1): 112-114
Bathla G, Hegde AN. MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adults. Clin Radiol 2013; 68(6): 545-554
Cherian A, Thomas B, Baheti NN, et al. Concepts and controversies in nonketotic hyperglycemia-induced hemichorea: further evidence from susceptibility-weighted MR imaging. J Magn Reson Imaging 2009; 29(3): 699-703
Portet F, Brickman AM, Stem Y, et al. Metabolic syndrome and localization of white matter hyperintensities in the elderly population. Alzheimers Dement 2012; 8(5, Suppl): S88-95.el
Shrier DA, Shibata DK, Wang HZ, et al. Central brain herniation secondary to juvenile diabetic ketoacidosis. AJNR Am J Neuroradiol 1999; 20(10): 1885-1888
Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008; 29(6): 1036-1042
Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008; 29(6): 1043-1049
Dicuonzo F, Salvati A, Palma M, et al. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings. J Child Neurol 2009; 24(8): 1013-1018
Stevens CJ, Heran MKS. The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 2012; 85(1020): 1566-1575
Yilmaz S, Gokben S, Arikan C, et al. Reversibility of cytotoxic edema in tacrolimus leukoencephalopathy. Pediatr Neurol 2010; 43(5): 359-362
Cilia R, Righini A, Marotta C, et al. Clinical and imaging characterization of a patient with idiopathic progressive ataxia and palatal tremor. Eur J Neurol 2007; 14(8): 944-946
Goyal M, Versnick E, Tuite P, et al. Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings. AJNR Am J Neuroradiol 2000; 21(6): 1073-1077
Kim SJ, Lee JH, Suh DC. Cerebellar MR changes in patients with olivary hypertrophic degeneration. AJNR Am J Neuroradiol 1994; 15(9): 1715-1719
Kitajima M, Korogi Y, Shimomura O, et al. Hypertrophic olivary degeneration: MR imaging and pathologic findings. Radiology 1994; 192(2): 539-543
Palacios E, Wasilewska E, Alvernia JE, Figueroa RE. Palatal myoclonus secondary to hypertrophic olivary degeneration. Ear Nose Throat J 2009; 88(7): 989-991
Sanverdi SE, Oguz KK, Haliloglu C. Hypertrophic olivary degeneration in children: four cases and a review of the literature. Br J Radiol 2012; 85: 511-516
Shah R, Markert J, Bag AK, Cure JK. Diffusion tensor imaging in hypertrophic olivary degeneration. AJNR Am J Neuroradiol 2010; 31(9): 1729-1731
Vossough A, Ziai P, Chatzkel JA. Red nucleus degeneration in hypertrophic olivary degeneration after pediatric posterior fossa tumor resection: use of susceptibility-weighted imaging (SWI). Pediatr Radiol 2012; 42(4): 481-485
Atay M, Aralasmak A, Sharifov R, et al. Transient cytotoxic edema caused by hypoglycemia: follow-up diffusion-weighted imaging features. Emerg Radiol 2012; 19(5): 473-475
Johkura K, Nakae Y, Kudo Y, et al. Early diffusion MR imaging findings and short-term outcome in comatose patients with hypoglycemia. AJNR Am J Neuroradiol 2012; 33(5): 904-909
Yong AW, Morris Z, Shuler K, et al. Acute symptomatic hypoglycaemia mimicking ischaemic stroke on imaging: a systemic review. BMC Neurol 2012; 12: 139
Amstutz DR, Coons SW, Kerrigan JF, et al. Hypothalamic hamartomas: Correlation of MR imaging and spectroscopic findings with tumor glial content. AJNR Am J Neuroradiol 2006; 27(4): 794-798
Freeman JL, Coleman LT, Wellard RM, et al. MR imaging and spectroscopic study of epileptogenic hypothalamic hamartomas: analysis of 72 cases. AJNR Am J Neuroradiol 2004; 25(3): 450-J62
Maixner W. Hypothalamic hamartomas - clinical, neuro- I pathological and surgical aspects. Childs Nerv Syst 2006; 22(8): 867-873
Mathieu D, Deacon C, Pinard CA, et al. Gamma Knife surgery for hypothalamic hamartomas causing refractory epilepsy: preliminary results from a prospective observational study. J Neurosurg 2010; 113(Suppl): 215-221
Parvizi J, Le S, Foster BL, et al. Gelastic epilepsy and hypothalamic hamartomas: neuroanatomical analysis of brain lesions in 100 patients. Brain 2011; 134(Pt 10): 2960-2968
Saleem SN, Said AHM, Lee DH. Lesions of the hypothalamus: MR imaging diagnostic features. Radiographics 2007; 27(4): 1087-1108
Franco Folino A. Cerebral autoregulation and syncope. Prog Cardiovasc Dis 2007; 50(1): 49-80
Huang BY, Castillo M. Hypoxic-ischemic brain injury: imaging findings from birth to adulthood. Radiographics 2008; 28(2): 417-439, quiz 617
Kanekar SG, Zacharia T, Roller R. Imaging of stroke: Part 2, Pathophysiology at the molecular and cellular levels and corresponding imaging changes. AJR Am J Roentgenol 2012; 198(1): 63-74
Kucinski T. Unenhanced CT and acute stroke physiology. Neuroimaging Clin N Am 2005; 15(2): 397-407, xi-xii
Lee EJ, Lee YJ, Lee SR, et al. Hypereosinophilia with multiple thromboembolie cerebral infarcts and focal intracerebral hemorrhage. Korean J Radiol 2009; 10(5): 511-514
Kono Y, Itoh Y. Diffusion-weighted imaging of encephalopathy related to idiopathic hyper?osinophilie syndrome. Clin Neurol Neurosurg 2009; 111(6): 551-553
Lury ÊÌ. Inflammatory and infectious processes involving the pituitary gland. Top Magn Reson Imaging 2005; 16(4): 301-306
Santoro SG, Guida AH, Furioso AE, et al. Panhypopituitarism due to Wegener’s granulomatosis. Arq Bras Endocrinol Metabol 2011; 55(7): 481-485
Yong TY, Li JYZ, Amato L, et al. Pituitary involvement in Wegener’s granulomatosis. Pituitary 2008; 11(1): 77-84
Anzalone N, Scotti R, Riva R. Neuroradiologic differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci 2004; 25(Suppl 1 ): S3-S5
Dainer HM, Smirniotopoulos JG. Neuroimaging of hemorrhage and vascular malformations. Semin Neurol 2008; 28(4): 533-547
Kubal WS. Updated imaging of traumatic brain injury. Radiol Clin North Am 2012; 50(1): 15^11
Leblanc GG, Golanov E, Awad 1A, Young WL; Biology of Vascular Malformations of the Brain NINDS Workshop Collaborators. Biology of vascular malformations of the brain. Stroke 2009; 40(12): e694-e702
Parizel PM, Makkat S, Van Miert E, et al. Intracranial hemorrhage: principles of CT and MRi interpretation. Eur Radiol 2001; 11(9): 1770-1783
Riant F, Cecillon M, Saugier-Veber P, Toumier-Lasserve E. CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions. Neurogenetics 2013; 14(2): 133-141
Smith EE, Rosand J, Greenberg SM. Hemorrhagic stroke. Neuroimaging Clin N Am 2005; 15(2): 259-272, ix
Duning T, Deppe M, Keller S, et al. Diffusion tensor imaging in a case of Kearns-Sayre syndrome: striking brainstem involvement as a possible cause of oculomotor symptoms. J Neurol Sci 2009; 281(1-2): 110-112
van der Knaap M, Valk J. Keams-Sayre syndrome. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 215-220
Paulus W, Perry A. Histiocytic tumours. In: Louis DN, Oh-gaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 193-196
Baertling F, Rodenburg RJ, Schaper J, et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry 2014; 85(3): 257-265
Akhaddar A, Zyani M, Mikdame M, Boucetta M. Acute myeloid leukemia with brain involvement (chloroma). Intern Med 2011; 50(5): 535-536
Cho SF, Liu TC, Chang CS. Isolated central nervous system relapse presenting as myeloid sarcoma of acute myeloid leukemia after allogeneic peripheral blood stem cell transplantation. Ann Hematol 2013; 92(1): 133-135
Hakyemez B, Yildirim N, Taskapilioglu O, et al. Intracranial myeloid sarcoma: conventional and advanced MRI findings. Br J Radiol 2007; 80(954): el09-ell2
Laningham FH, Kun LE, Reddick WE, et al. Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae. Neuro radiology 2007; 49(11): 873-888
Barkovich AJ, Patay Z. Metabolic, toxic and inflammatory brain disorders. In: Barkovich AJ, Raybaud C, eds. Pediatric Neuroimaging. 5th ed. New York, NY: Wolters-Kluwer/Lip-pincott Williams & Wilkins, 2012: 81-239
Bizzi A, Castelli G, Bugiani M, et al. Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2008; 29(7): 1270-1275
Engelbrecht V, Scherer A, Rassek M, et al. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 2002; 222(2): 410-418
Kaye EM, Moser H. Where has all the white matter gone? Unraveling the mysteries of leukoencephalopathies. Neurology 2004; 62(9): 1464-1465
Lyon G, Fattal-Valevski A, Kolodny EH. Leukodystrophies: clinical and genetic aspects. Top Magn Reson Imaging 2006; 17(4): 219-242
Osborn AG. Inherited metabolic disorders. In: Osborn AG. Osborn’s Brain: Imaging, Pathology, and Anatomy. Salt Lake City, UT: Amirsys, 2013: 853-905
Perlman SJ, Mar S. Leukodystrophies. In: Ahmad SI, ed. Neurodegenerative Diseases. Austin TX: Landes Bioscience/ Springer Science, 2012: 154-171
Phelan JA, Lowe LH, Glasier CM. Pediatric neurodegenerative white matter processes: leukodystrophies and beyond. Pediatr Radiol 2008; 38(7): 729-749
van der Knaap MS, Naidu S, Pouwels PJW, et al. New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum. AJNR Am J Neuroradiol 2002; 23(9): 1466-1474
van der Knapp MS, Valk J. Leukoencephalopathy with vanishing white matter. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 481-485
van der Voom JP, Pouwels PJW, Hart AAM, et al. Childhood white matter disorders: quantitative MR imaging and spectroscopy. Radiology 2006; 241(2): 510-517
Jabot G, Stoquart-Elsankari S, Saliou G, et al. Intracranial lipomas: clinical appearances on neuroimaging and clinical significance. J Neurol 2009; 256(6): 851-855
Mukherjee P, Street I, Irving RM. Intracranial lipomas affecting the cerebellopontine angle and internal auditory canal: a case series. Otol Neurotol 2011; 32(4): 670-675
Sommet J, Schiff M, Evrard P, et al. Pericallosal lipoma and middle cerebral artery aneurysm: a coincidence? Pediatr Radiol 2010; 40(8): 1417-1420
Yildiz H, Hakyemez B, Koroglu M, et al. Intracranial lipomas: importance of localization. Neuroradiology 2006; 48(1): 1-7
Khayal IS, Vandenberg SR, Smith KJ, et al. MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neurooncol 2011; 13(11): 1192-1201
Poretti A, Meoded A, Huisman TAGM. Neuroimaging of pediatric posterior fossa tumors including review of the literature. J Magn Reson Imaging 2012; 35(1): 32—47
Rumboldt Z, Camacho DLA, Lake D, et al. Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006; 27(6): 1362-1369
Siegal T. Clinical impact of molecular biomarkers in gliomas. J Clin Neurosci 2015; 22: 437^144
von Deimling A, Burger PC, Nakazato Y, et al. Diffuse astrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 25-29
Hildenbrand P, Craven DE, Jones R, Nemeskal P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol 2009; 30(6): 1079-1087
Deckert M, Paulus W. Malignant lymphomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 188-192
Doskaliyev A, Yamasaki F, Ohtaki M, et al. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at3T. Eur J Radiol 2012; 81(2): 339-344
Lueth M, Stein H, Spors B, et al. First case report of a peripheral T-cell lymphoma, not otherwise specified, of the central nervous system in a child. J Pediatr Hematol Oncol 2012; 34(2): e66-e68
Tang YZ, Booth TC, Bhogal P, et al. Imaging of primary central nervous system lymphoma. Clin Radiol 2011; 66(8): 768-777
Toh CH, Castillo M, Wong AM, et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008; 29(3): 471-475
Villano JL, Koshy M, Shaikh H, et al. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer 2011; 105(9): 1414-1418
Zhu JQ, Hao NX, Bao WQ, Wu XR. Multiple calcified primary central nervous system lymphoma with immunodeficiency in a child. World J Pediatr 2011; 7(3): 277-279
Potchen MJ, Kampondeni SD, Seydel KB, et al. Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease. AJNR Am J Neuroradiol 2012; 33(9): 1740-1746
Seydel KB, Kampondeni SD, Valim C, et al. Brain swelling and death in children with cerebral malaria. N Engl J Med 2015; 372(12): 1126-1137
Choi JH, Choi KD, Kim JS, et al. Simultaneous posterior ischemic optic neuropathy, cerebral border zone infarction, and spinal cord infarction after correction of malignant hypertension. J Neuroophthalmol 2008; 28(3): 198-201
Cruz-Flores S, de Assis Aquino Gondim F, Leira EC. Brainstem involvement in hypertensive encephalopathy: clinical and radiological findings. Neurology 2004; 62(8): 1417-1419
Eguchi K, Kasahara K, Nagashima A, et al. Two cases of malignant hypertension with reversible diffuse leukoencephalopathy exhibiting a reversible nocturnal blood pressure «riser» pattern. Hypertens Res 2002; 25(3): 467 473
Elliott WJ. Clinical features and management of selected hypertensive emergencies. J Clin Hypertens (Greenwich) 2004; 6(10): 587-592
Feldstein C. Management of hypertensive crises. Am J Ther 2007; 14(2): 135-139
Garewal M, Yahya S, Ward C, et al. MRI changes in thrombotic microangiopathy secondary to malignant hypertension. J Neuroimaging 2007; 17(2): 178-180
Íà JS, Kim ÒÊ, Eun BL, et al. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI. Pediatr Radiol 2004; 34(2): 163-166
Jan W, Zimmerman RA, Wang ZJ, et al. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 2003; 45(6): 393-399
Parmar H, Sitoh YY, Ho L. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings. J Comput Assist Tomogr 2004; 28(1): 93-97
Sakai M, Inoue Y, Oba H, et al. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy. J Comput Assist Tomogr 2005; 29(4): 524-527
Giangaspero F, Eberhart CG, Haapasalo H, et al. Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 132-140
Isaacs H. Fetal brain tumors: a review of 154 cases. Am J Perinatol 2009; 26(6): 453—466
Koeller KK, Rushing EJ. From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation. Radiographics 2003; 23(6): 1613— 1637
McLendon RE, Judkins AR, Eberhart CG, et al. Central nervous system primitive neuroectodermal tumours. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 141-146
Mehrotra N, Shamji MF, Vassilyadi M, Ventureyra EC. Intracranial tumors in first year of life: the CHEO experience. Childs Nerv Syst 2009; 25(12):! 563-1569
Meyers SP, Wildenhain SL, Chang JK, et al. Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes. AJNR Am J Neuroradiol 2000; 21(9): 1757-1765
Meyers SP, Wildenhain S, Chess MA, Tarr RW. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine. AJNR Am J Neuroradiol 1994; 15(8): 1425-1434
Meyers SP, Kemp SS, Tarr RW. MR imaging features of medulloblastomas. AJR Am J Roentgenol 1992; 158(4): 859-865
Yeom KW, Mobley BC, Lober RM, et al. Distinctive MR1 features of pediatric medulloblastoma subtypes. AJR Am J Roentgenol 2013; 200(4): 895-903
Barkovich AJ, Patay Z. Metabolic, toxic and inflammatory brain disorders. In: Barkovich AJ, Raybaud C, eds. Pediatric Neuroimaging. 5th ed. New York, NY: Wolters-Kluwer/Lip-pincott Williams & Wilkins, 2012: 81-239
Lopez-Hernandez T, Sirisi S, Capdevila-Nortes X, et al. Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts. Hum Mol Genet 2011; 20(16): 3266-3277
Osborn AG. Inherited metabolic disorders. In: Osborn AG. Osborn’s Brain: Imaging, Pathology, and Anatomy. Salt Lake City, UT: Amirsys, 2013: 853-905
van der Knaap MS, Boor I, Estevez R. Megalencephalic leukoencephalopathy with subcortical cysts: chronic white matter oedema due to a defect in brain ion and water homoeo-stasis. Lancet Neurol 2012; 11(11): 973-985
van der Knaap M, Valk J. Megalencephalic leukoencephalopathy with subcortical cysts. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 442-450
Diogo L, Cordeiro M, Garcia P, et al. Value of brain magnetic resonance imaging in mitochondrial respiratory chain disorders. Pediatr Neurol 2010; 42(3): 196-200
Sofou K, Steneryd K, Wiklund LM, et al. MR1 of the brain in childhood-onset mitochondrial disorders with central nervous system involvement. Mitochondrion 2013; 13(4): 364-371
Kashlan ON, Laborde DV, Davison L, et al. Meningioan-giomatosis: a case report and literature review emphasizing diverse appearance on different imaging modalities. Case Rep Neurol Med 2011; 2011: 361203
Rokes C, Ketonen LM, Fuller GN, et al. Imaging and spectroscopic findings in meningioangiomatosis. Pediatr Blood Cancer 2009; 53(4): 672-674
Yao Z, Wang Y, Zee C, et al. Computed tomography and magnetic resonance appearance of sporadic meningioangiomatosis correlated with pathological findings. J Comput Assist Tomogr 2009; 33(5): 799-804
Bamerias C, Boddaert N, Guiraud P, et al. Unusual magnetic resonance imaging features in Menkes disease. Brain Dev 2008; 30(7): 489-492
Bekiesinska-Figatowska M, Rokicki D, Walecki J, Gremi-da M. Menkes’ disease with a Dandy-Walker variant: case report. Neuroradiology 2001; 43(11): 948-950
Ito H, Mori K, Sakata M, et al. Transient left temporal lobe lesion in Menkes disease may influence the generation of tonic spasms. Brain Dev 2011; 33(4): 345-348
Jaspan T. Current controversies in the interpretation of nonaccidental head injury. Pediatr Radiol 2008; 38(Suppl 3): S378-S387
Koprivsek K, Lucic M, Kozic D, et al. Basal ganglia lesions in the early stage of Menkes disease. J Inherit Metab Dis 2010; 33(3): 301-302
Moser FG, Samat HB, Maya MM, Menkes JH. Corkscrew basilar artery as an incidental finding on neuroimaging. Pediatr Neurol 2007; 37(5): 375-377
Nassogne MC, Sharrard M, Hertz-Pannier L, et al. Massive subdural haematomas in Menkes disease mimicking shaken baby syndrome. Childs Nerv Syst 2002; 18(12): 729-731
Toldo I, Carollo C, Battistella PA, Laverda AM. Spinal cord and cauda equina MRI findings in metachromatic leukodystrophy: case report. Neuroradiology 2005; 47(8): 572-575
van der Voom JP, Pouwels PJ, Kamphorst W, et al. Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders. AJNR Am J Neuroradiol 2005; 26(3): 442-446
Mitsuya K, Nakasu Y, Horiguchi S, et al. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 2010; 99(1): 81-88
Toh CH, Wei ÊÑ, Ng SH, et al. Differentiation of brain abscesses from necrotic glioblastomas and cystic metastatic brain tumors with diffusion tensor imaging. AJNR Am J Neuroradiol 2011; 32(9): 1646-1651
Wang W, Steward CE, Desmond PM. Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy. AJNR Am J Neuroradiol 2009; 30(1): 203-208
Wesseling P, von Deimling A, Aidape KD. Metastatic tumours of the CNS. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 248-251
Kose D, Karabagli P, Yavas G, et al. Intracranial metastasis of neuroblastoma: in two different areas at the same time. Childs Nerv Syst 2013; 29(10): 1799-1802
Paulino AC, Mai WY, Teh BS. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol 2013; 36(3): 283-286
Rabah F, Al-Mashaikhi N, Beshlawi I, et al. Brain is not always the last fortress; osteosarcoma with large brain metastasis. J Pediatr Hematol Oncol 2013; 35(2): e91-e93
Arora V, Nijjar IB, Multani AS, et al. MRI findings in methanol intoxication: a report of two cases. Br J Radiol 2007; 80(958): e243-e246
Bhatia R, Kumar M, Garg A, Nanda A. Putaminal necrosis due to methanol toxicity. Pract Neurol 2008; 8(6): 386-387
Kruse JA. Methanol and ethylene glycol intoxication. Crit Care Clin 2012; 28(4): 661-711
Takao H, Doi 1, Watanabe T. Serial diffusion-weighted magnetic resonance imaging in methanol intoxication. J Comput Assist Tomogr 2006; 30(5): 742-744
Burlina AP, Manara R, Calderone M, et al. Diffusion-weighted imaging in the assessment of neurological damage in patients with methylmalonic aciduria. J Inherit Metab Dis 2003; 26(5): 417—422
Carrozzo R, Dionisi-Vici C, Steuerwald U, et al. SU-CLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 2007; 130(Pt 3): 862-874
Ostergaard E, Schwartz M, Batbayli M, et al. A novel missense mutation in SUCLC1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria. Eur J Pediatr 2010; 169(2): 201-205
Rossi A, Cerone R, Biancheri R, et al. Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings. AJNR Am J Neuroradiol 2001; 22(3): 554-563
Ye?ildag A, Ayata A, Baykal B, et al. Magnetic resonance imaging and diffusion-weighted imaging in methylmalonic acidemia. Acta Radiol 2005; 46(1): 101-103
Adachi Y, Poduri A, Kawaguch A, et al. Congenital microcephaly with a simplified gyral pattern: associated findings and their significance. AJNR Am J Neuroradiol 2011 ; 32(6): 1123-1129
Poulton CJ, Schot R, Kia SK, et al. Microcephaly with simplified gyration, epilepsy, and infantile diabetes linked to inappropriate apoptosis of neural progenitors. Am J Hum Genet 2011; 89(2): 265-276
Mascalchi M, Vella A, Ceravolo R. Movement disorders: role of imaging in diagnosis. J Magn Reson Imaging 2012; 35(2): 239-256
Chapman T, Matesan M, Weinberger E, Bulas DI. Digital atlas of fetal brain MRI. Pediatr Radiol 2010; 40(2): 153-162
Kostovic I, Vasung L. Insights from in vitro fetal magnetic resonance imaging of cerebral development. Semin Perinatol 2009; 33(4): 220-233
Manganaro L, Perrone A, Savelli S, et al. Evaluation of normal brain development by prenatal MR imaging. Radiol Med (Torino) 2007; 112(3): 444^155
Rados M, Judas M, Kostovic I. In vitro MRI of brain development. Eur J Radiol 2006; 57(2): 187-198
Shekdar K, Feygin T. Fetal neuroimaging. Neuroimaging Clin N Am 2011; 21(3): 677-703, ix
Davison JE, Hendriksz CJ, Sun Y, et al. Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome). J Inherit Metab Dis 2010; 33(Suppl 3): S395-S399
Finn CT, Vedolin L, Schwartz IV, et al. Magnetic resonance imaging findings in Hunter syndrome. Acta Paediatr 2008; 97(457): 61-68
Horovitz DDG, Magalhaes TdeS, Pena e Costa A, et al. Spinal cord compression in young children with type VI mucopolysaccharidosis. Mol Genet Metab 2011; 104(3): 295-300
Iyer RS, Khanna PC. Intracranial findings of Hunter syndrome. Pediatr Radiol 2010; 40(Suppl 1): SI 73
Kara S, Sherr EH, Barkovich AJ. Dilated perivascular spaces: an informative radiologic finding in Sanfilippo syndrome type A. Pediatr Neurol 2008; 38(5): 363-366
Lee C, Dineen ÒÅ, Brack M, et al. The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR Am J Neuroradiol 1993; 14(6): 1285-1292
Li MF, Chiu PC, Weng MJ, Lai PH. Atlantoaxial instability and cervical cord compression in Morquio syndrome. Arch Neurol 2010; 67( 12): 1530 (formerly Archives of Neurology)
Manara R, Priante E, Grimaldi M, et al. Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis 2011; 34(3): 763-780
Martin R, Beck M, Eng C, et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 2008; 121(2): e377-e386
Matheus MG, Castillo M, Smith JK, et al. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004; 46(8): 666-672
Rasalkar DD, Chu WCW, Hui J, et al. Pictorial review of mucopolysaccharidosis with emphasis on MRI features of brain and spine. Br J Radiol 2011; 84( 1001): 469 477
van der Knaap M, Valk J. Mucopolysaccharidoses. In: van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. New York: Springer, 2005: 123-136
Vedolin L, Schwartz IVD, Komlos M, et al. Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 2007; 69(9): 917-924
Vedolin L, Schwartz IVD, Komlos M, et al. Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am J Neuroradiol 2007; 28(6): 1029-1033
White KK, Karol LA, White DR, Hale S. Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III). J Pediatr Orthop 2011; 31 (5): 594-598
Wraith JE, Scarpa M, Beck M, et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 2008; 167(3): 267-277
Filippi M. Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis. Nat Rev Neurol 2011; 7(2): 74-75
Inglese Ì, Petracca Ì. Imaging multiple sclerosis and other neurodegenerative diseases. Prion 2013; 7(1): 47-54
Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9(5): A387-A394
Minagar A, Barnett MH, Benedict RHB, et al. The thalamus and multiple sclerosis: modem views on pathologic, imaging, and clinical aspects. Neurology 2013; 80(2): 210-219
Sheremata W, Tomes L. Multiple sclerosis and the spinal cord. Neurol Clin 2013; 31(1): 55-77
Iodice V, Lipp A, Ahlskog JE, et al. Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry 2012; 83(4): 453-459
Ito S, Shirai W, Hattori T. Putaminal hyperintensity on Tl-weighted MR imaging in patients with the Parkinson variant of multiple system atrophy. AJNR Am J Neuroradiol 2009; 30(4): 689-692
Massey LA, Jager HR, Paviour DC, et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013; 80(20): 1856-1861
Matsusue E, Fujii S, Kanasaki Y, et al. Cerebellar lesions in multiple system atrophy: postmortem MR imaging-pathologic correlations. AJNR Am J Neuroradiol 2009; 30(9): 1725-1730
Nair SR, Tan LK, Mohd Ramli N, et al. A decision tree for differentiating multiple system atrophy from Parkinson’s disease using 3-T MR imaging. Eur Radiol 2013; 23(6): 1459-1466
Nicoletti G, Rizzo G, Barbagallo G, et al. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy - Richardson syndrome and Parkinson disease. Radiology 2013; 267(3): 843-850
Okamoto K, Tokiguchi S, Furusawa T, et al. MR features of diseases involving bilateral middle cerebellar peduncles. AJNR Am J Neuroradiol 2003; 24(10): 1946-1954
Paviour DC, Price SL, Jahanshahi M, et al. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006; 129(Pt 4): 1040-1049
Savoiardo M, Strada L, Girotti F, et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990; 174(3 Pt 1): 693-696
Shrivastava A. The hot cross bun sign. Radiology 2007; 245(2): 606-607
Tsukamoto K, Matsusue E, Kanasaki Y, et al. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson’s disease: evaluation by 3.0-T MR imaging. Neuroradiology 2012; 54(9): 947-955
Boichot C, Walker PM, Durand C, et al. Term neonate prognoses after perinatal asphyxia: contributions of MR imaging, MR spectroscopy, relaxation times, and apparent diffusion coefficients. Radiology 2006; 239(3): 839-848
Grant PE, Yu D. Acute injury to the immature brain with hypoxia with or without hypoperfusion. Magn Reson Imaging Clin N Am 2006; 14(2): 271-285
Heinz ER, Provenzale JM. Imaging findings in neonatal hypoxia: a practical review. AJR Am J Roentgenol 2009; 192(1): 41^47
Huang BY, Castillo M. Hypoxic-ischemic brain injury: imaging findings from birth to adulthood. Radiographics 2008; 28(2): 417 439, quiz 617
Liauw L, Palm-Meinders IH, van der Grand J, et al. Differentiating normal myelination from hypoxic-ischemic encephalopathy on Tl-weighted MR Images: a new approach. AJNR Am J Neuroradiol 2007; 28(4): 660-665
Liauw L, van der Grand J, van den Berg-Huysmans AA, et al. Is there a way to predict outcome in (near) term neonates with hypoxic-ischemic encephalopathy based on MR imaging? AJNR Am J Neuroradiol 2008; 29(9): 1789-1794
Liauw L, van der Grand J, van den Berg-Huysmans AA, et al. Hypoxic-ischemic encephalopathy: diagnostic value of conventional MR imaging pulse sequences in term-born neonates. Radiology 2008; 247(1): 204-212
Liauw L, van Wezel-Meijler G, Veen S, et al. Do apparent diffusion coefficient measurements predict outcome in children with neonatal hypoxic-ischemic encephalopathy? AJNR Am J Neuroradiol 2009; 30(2): 264-270
Nikas I, Dermentzoglou V, Theofanopoulou M, Theodo-ropoulos V. Parasagittal lesions and ulegyria in hypoxic-ischemic encephalopathy: neuroimaging findings and review of the pathogenesis. J Child Neurol 2008: 23(1): 51-58
Zarifi MK, Astrakas LG, Poussaint TY, et al. Prediction of adverse outcome with cerebral lactate level and apparent diffusion coefficient in infants with perinatal asphyxia. Radiology 2002; 225(3): 859-870
Brat DJ, Perry A. Melanocyte lesions. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 181-183
Di Rocco F, Sabatino G, Koutzoglou M, et al. Neurocutaneous melanosis. Childs Nerv Syst 2004; 20(1): 23-28
Hayashi M, Maeda M, Maji T, et al. Diffuse leptomeningeal hyperintensity on fluid-attenuated inversion recovery MR images in neurocutaneous melanosis. AJNR Am J Neuroradiol 2004; 25(1): 138-141
Ramaswamy V, Delaney H, Haque S, et al. Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis. Dev Med Child Neurol 2012; 54(6): 563-568
Lerner A, Shiroishi MS, Zee CS, et al. Imaging of neurocysticercosis. Neuroimaging Clin N Am 2012; 22(4): 659-676
Schuff N, Zhu XP. Imaging of mild cognitive impairment and early dementia. Br J Radiol 2007; 80(Spec No 2): S109-S114
Snowden JS, Thompson JC, Stopford CL, et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011; 134(Pt 9): 2478-2492
Sullivan EV, Pfefferbaum A. Neuroradiological characterization of normal adult ageing. Br J Radiol 2007; 80(Spec No 2): S99-S108
Tartaglia MC, Rosen HJ, Miller BL. Neuroimaging in dementia. Neurotherapeutics 2011; 8(1): 82-92
Vitali P, Migliaccio R, Agosta F, et al. Neuroimaging in dementia. Semin Neurol 2008; 28(4): 467—483
Guermazi A, Miaux Y, Majoulet JF, et al. Imaging findings of central nervous system neuroepithelial cysts. Eur Radiol 1998; 8(4): 618-623
Ormond DR, Omeis 1, Mohan A, et al. Obstructive hydrocephalus due to a third ventricular neuroepithelial cyst. J Neurosurg Pediatr2008; 1(6): 481-484
Uematsu Y, Kubo K, Nishibayashi T, et al. Interhemispheric neuroepithelial cyst associated with agenesis of the corpus callosum. A case report and review of the literature. Pediatr Neurosurg 2000; 33( 1 ): 31-36
Ginat DT, Meyers SP. Intracranial lesions with high signal intensity on Tl-weighted MR images: differential diagnosis. Radiographics 2012; 32(2): 499-516
Mentzel HJ, Seidel J, Fitzek C, et al. Pediatric brain MRI in neurofibromatosis type 1. Eur Radiol 2005; 15(4): 814-822
Terada H, Barkovich AJ, Edwards MSB, Ciricillo SM. Evolution of high-intensity basal ganglia lesions on Tl-weighted MR in neurofibromatosis type 1. AJNR Am J Neuroradiol 1996; 17(4): 755-760
von Deimling A, Perry A. Neurofibromatosis type 1. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: I ARC Press, 2007: 206-209
Gao GK, Wu D, Yang Y, et al. Cerebral magnetic resonance imaging of compressed air divers in diving accidents. Undersea Hyperb Med 2009; 36(1): 33—41
Jersey SL, Jesinger RA, Palka P. Brain magnetic resonance imaging anomalies in U-2 pilots with neurological decompression sickness. Aviat Space Environ Med 2013; 84(1): 3-11
Ozdoba C, Weis J, Plattner T, et al. Fatal scuba diving incident with massive gas embolism in cerebral and spinal arteries. Neuroradiology 2005; 47(6): 411—416
Paniagua Bravo A, Forkert ND, Schulz A, et al. Quantitative t2 measurements in juvenile and late infantile neuronal ceroid lipofuscinosis. Clin Neuroradiol 2013; 23(3): 189-196
Dyke JP, Voss HU, Sondhi D, et al. Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imaging. AJNR Am J Neuroradiol 2007; 28(7): 1232-1236
Kohlschiitter A, Schulz A. Towards understanding the neuronal ceroid lipofuscinoses. Brain Dev 2009; 31(7): 499-502
Mink JW, Augustine EF, Adams HR, et al. Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol 2013; 28(9): 1101-1105
Mole SE, Cotman SL. Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochimica et Biophysica Acta 2015;1852: 2237-2241
Spalice A, Parisi P, Nicita F, et al. Neuronal migration disorders: clinical, neuroradiology and genetics aspects. Acta Paediatr 2009; 98(3): 421-433
Koyama T, Ueda H, Togashi K, et al. Radiologic manifestations of sarcoidosis in various organs. Radiographics 2004; 24(1): 87-104
Spencer TS, Campellone JV, Maldonado I, et al. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 2005; 34(4): 649-661
Daams M, Schuitema I, van Dijk BW, et al. Long-term effects of cranial irradiation and intrathecal chemotherapy in treatment of childhood leukemia: a MEG study of power spectrum and correlated cognitive dysfunction. BMC Neurol 2012; 12: 84
Inaba H, Khan RB, Laningham FH, et al. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 2008; 19(1): 178-184
Laningham FH, Kun LE, Reddick WE, et al. Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae. Neuroradiology 2007; 49(11): 873-888
Wells EM, Nageswara Rao AA, Scafidi J, Packer RJ. Neurotoxicity of biologically targeted agents in pediatric cancer trials. Pediatr Neurol 2012; 46(4): 212-221
Yoshida S, Hayakawa K, Yamamoto A, et al. The central nervous system complications of bone marrow transplantation in children. Eur Radiol 2008; 18(10): 2048-2059
Bode-Janisch S, Biiltmann Å, Hartmann Í, et al. Serious head injury in young children: birth trauma versus non-accidental head injury. Forensic Sci Int 2012; 214(1-3): e34-e38
Demaerel P. MR imaging in inflicted brain injury. Magn Reson Imaging Clin N Am 2012; 20( 1): 35-44
Ichord RN, Naim M, Pollock AN, et al. Hypoxic-ischemic injury complicates inflicted and accidental traumatic brain injury in young children: the role of diffusion-weighted imaging. J Neurotrauma 2007; 24(1): 106-118
Kemp AM, Rajaram S, Mann M, et al; Welsh Child Protection Systematic Review Group. What neuroimaging should be performed in children in whom inflicted brain injury (iBI) is suspected? A systematic review. Clin Radiol 2009; 64(5): 473-483
Piteau SJ, Ward MGK, Barrowman NJ, Plint AC. Clinical and radiographic characteristics associated with abusive and nonabusive head trauma: a systematic review. Pediatrics 2012; 130(2): 315-323
Rajaram S, Batty R, Rittey CDC, et al. Neuroimaging in non-accidental head injury in children: an important element of assessment. Postgrad Med J 2011; 87(1027): 355-361
Stoodley N. Radiology in non-accidental head injury. Paedi-atr Child Health (Oxford) 2009; 19(2): 90-92
Stoodley N. Neuroimaging in non-accidental head injury: if, when, why and how. Clin Radiol 2005; 60(1): 22-30
Tung GA, Kumar M, Richardson RC, et al. Comparison of accidental and nonaccidental traumatic head injury in children on noncontrast computed tomography. Pediatrics 2006; 118(2): 626-633
von Deimling A, Reifenberger G, Kros JM, et al. Oligoastrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 63-65
Khalid L, Carone M, Dumrongpisutikul N, et al. Imaging characteristics of oligodendrogliomas that predict grade. AJNR Am J Neuroradiol 2012; 33(5): 852-857
Kim JW, Park CK, Park SH, et al. Relationship between radiological characteristics and combined Ip and 19q deletion in World Health Organization grade Ill oligodendroglial tumours. J Neurol Neurosurg Psychiatry 2011; 82(2): 224-227
Reifenberger G, Kros JM, Louis DN, Collins VP. Oligodendroglioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 54-59
Choi CG, Yoo HW. Localized proton MR spectroscopy in infants with urea cycle defect. AJNR Am J Neuroradiol 2001; 22(5): 834-837
Gropman A. Brain imaging in urea cycle disorders. Mol Genet Metab 2010; 100(Suppl 1): S20-S30
Gropman AL, Sailasuta N, Harris ÊÑ, et al. Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults. Radiology 2009; 252(3): 833-841
Michalak A, Butterworth RF. Ornithine transcarbamylase deficiency: pathogenesis of the cerebral disorder and new prospects for therapy. Metab Brain Dis 1997; 12(3): 171-182
Parmar H, Sitoh YY, Ho L. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings. J Comput Assist Tomogr 2004; 28(1): 93-97
Schwab S, Schwarz S, Mayatepek E, Hoffmann GF. Recurrent brain edema in omithine-transcarbamylase deficiency. J Neurol 1999; 246(7): 609-611
Sener RN. Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders. Acta Radiol 2004; 45(5): 561-570
Takanashi J, Barkovich AJ, Cheng SF, et al. Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders. AJNR Am J Neuroradiol 2003; 24(6): 1184-1187
Guzman-De-Villoria J A, Ferreiro-Argiielles C, Fernandez-Garcia P. Differential diagnosis of T2 hyperintense brainstem lesions: Part 2. Diffuse lesions. Semin Ultrasound CT MR 2010; 31(3): 260-274
Ranger AM, Chaudhary N, Avery M, Fraser D. Central pontine and extrapontine myelinolysis in children: a review of 76 patients. J Child Neurol 2012; 27(8): 1027-1037
Guridi J, Obeso JA. The subthalamic nucleus, hemiballis-mus and Parkinson’s disease: reappraisal of a neurosurgical dogma. Brain 2001; 124(Pt 1): 5-19
Hsu C, Kwan G, Lau Q, Bhuta S. Rosette-forming glioneu-ronal tumour: imaging features, histopathological correlation and a comprehensive review of literature. Br J Neurosurg 2012; 26(5): 668-673
Mahajan H, Varikatt W, Dexter M, et al. Papillary glioneu-ronal tumor of the frontal lobe. J Clin Neurosci 2010; 17(4): 534-536
Marhold F, Preusser M, Dietrich W, et al. Clinicoradiological features of rosette-forming glioneuronal tumor (RGNT) of the fourth ventricle: report of four cases and literature review. J Neurooncol 2008; 90(3): 301-308
Nakazato Y, Figarella-Branger D, Becker AJ, et al. Papillary glioneuronal tumour. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 113-114
Buffenoir Ê, Rigoard Ð, Wager Ì, et al. Papillary tumor of the pineal region in a child: case report and review of the literature. Childs Nerv Syst 2008; 24(3): 379-384
Chang AH, Fuller GN, Debnam JM, et al. MR imaging of papillary tumor of the pineal region. AJNR Am J Neuroradiol 2008; 29(1): 187-189
Fevre-Montange M, Hasselblatt M, Figarella-Branger D, et al. Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases. J Neuropathol Exp Neurol 2006; 65(10): 1004-1011
Jouvet A, Nakazato Y, Scheithauer BW, Paulus W. Papillary tumour of the pineal region. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 128-129
Patel SK, Tomei KL, Christiano LD, et al. Complete regression of papillary tumor of the pineal region after radiation therapy: case report and review of the literature. J Neurooncol 2012; 107(2): 427-434
J?nior GV, Dellaretti Ì, de Carvalho GTC, et al. Papillary tumor of the pineal region. Brain Tumor Pathol 2011; 28(4): 329-334
Basu S, Alavi A. Role of FDG-ÐÅÒ in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol 2008; 10(3): 131-137
Gilmore CP, Elliott I, Auer D, Maddison P. Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration. J Neurol 2010; 257(3): 490^91
Karmon Y, Inbar E, Cordoba M, Gadoth N. Paraneoplastic cerebellar degeneration mimicking acute post-infectious cerebellitis. Cerebellum 2009; 8(4): 441-444
McKeon A, Ahlskog JE, Britton JW, et al. Reversible ex-tralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol 2009; 66(2): 268-271
McKeon A, Pittock SJ. Paraneoplastic encephalomyelopa-thies: pathology and mechanisms. Acta Neuropathol 2011; 122(4): 381 400
Shams’ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003; 126(Pt6): 1409-1418
Sioka C, Fotopoulos A, Kyritsis AP. Paraneoplastic neurological syndromes and the role of PET imaging. Oncology 2010; 78(2): 150-156
Smith JK. Parasellar tumors: suprasellar and cavernous sinuses. Top Magn Reson Imaging 2005; 16(4): 307-315
da Cunha Correia C, Ramos Lacerda H, de Assis Costa VM, Mertens de Queiroz Brainer A. Cerebral toxoplasmosis: unusual MRI findings. Clin Imaging 2012; 36(5): 462-465
Duishanbai S, Jiafu D, Guo H, et al. Intracranial hydatid cyst in children: report of 30 cases. Childs Nerv Syst 2010; 26(6): 821-827
Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, et al. Neurocysticercosis: radiologic-pathologic correlation. Radiographics 2010; 30(6): 1705-1719
Kumar GGS, Mahadevan A, Guruprasad AS, et al. Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature. J Magn Reson Imaging 2010; 31(6): 1469-1472
Lee GT, Antelo F, Mlikotic AA. Best cases from the AFIP: cerebral toxoplasmosis. Radiographics 2009; 29(4): 1200-1205
Masamed R, Meleis A, Lee EW, Hathout GM. Cerebral toxoplasmosis: case review and description of a new imaging sign. Clin Radiol 2009; 64(5): 560-563
Mohindra S, Savardekar A, Gupta R, et al. Varied types of intracranial hydatid cysts: radiological features and management techniques. Acta Neurochir (Wien) 2012; 154(1): 165-172
Nash ÒÅ, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 2011 ; 7(10): 584-594
Abdel Razek AA, Watcharakom A, Castillo M. Parasitic diseases of the central nervous system. Neuroimaging Clin NAm 2011; 21(4): 815-841, viii
Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003; 24(2): 197-211
Brooks DJ, Pavese N. Imaging biomarkers in Parkinson’s disease. Prog Neurobiol 2011; 95(4): 614-628
Ibarretxe-Bilbao N, Junque C, Marti MJ, Tolosa E. Brain structural MRI correlates of cognitive dysfunctions in Parkinson’s disease. J Neurol Sci 2011; 310(1-2): 70-74
Ibarretxe-Bilbao N, Tolosa E, Junque C, Marti MJ. MRI and cognitive impairment in Parkinson’s disease. Mov Disord 2009; 24(Suppl 2): S748-S753
Mascalchi M, Vella A, Ceravolo R. Movement disorders: role of imaging in diagnosis. J Magn Reson Imaging 2012; 35(2): 239-256
Pavese N, Brooks DJ. Imaging neurodegeneration in Parkinson’s disease. Biochim Biophys Acta 2009; 1792(7): 722-729
Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson’s disease: progress and therapeutic implications. Mov Disord 2013; 28(1): 14-23
Vaillancourt DE, Spraker MB, Prodoehl J, et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009; 72(16): 1378-1384
Hanefeld FA, Brockmann K, Pouwels PJW, et al. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination. Neurology 2005; 65(5): 701-706
Hoffman-Zacharska D, Kmiec T, Poznanski J, et al. Mutations in the PLP1 gene residue p. Glyl98 as the molecular basis of Pelizeaus-Merzbacher phenotype. Brain Dev 2013; 35(9): 877-880
Woodward KJ. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease. Expert Rev Mol Med 2008; 10:el4
Barkovich AJ, Westmark KD, Bedi HS, et al. Proton spectroscopy and diffusion imaging on the first day of life after perinatal asphyxia: preliminary report. AJNR Am J Neuroradiol 2001; 22(9): 1786-1794
Boichot C, Walker PM, Durand C, et al. Term neonate prognoses after perinatal asphyxia: contributions of MR imaging, MR spectroscopy, relaxation times, and apparent diffusion coefficients. Radiology 2006; 239(3): 839-848
Husson B, Lasjaunias P. Radiological approach to disorders of arterial brain vessels associated with childhood arterial stroke - a comparison between MRA and contrast angiography. Pediatr Radiol 2004; 34(1): 10-15
Rutherford MA, Ward P, Malamateniou C. Advanced MR techniques in the term-bom neonate with perinatal brain injury. Semin Fetal Neonatal Med 2005; 10(5): 445-460
Rutherford Ì, Srinivasan L, Dyet L, et al. Magnetic resonance imaging in perinatal brain injury: clinical presentation, lesions and outcome. Pediatr Radiol 2006; 36(7): 582-592
Bozzao A, Di Paolo A, Mazzoleni C, etal. Diffusion-weighted MR imaging in the early diagnosis of periventricular leukomalacia. Eur Radiol 2003; 13(7): 1571-1576
Fu J, Xue X, Chen L, et al. Studies on the value of diffusion-weighted MR imaging in the early prediction of periventricular leukomalacia. J Neuroimaging 2009; 19(1): 13-18
Kidokoro H, Kubota T, Ohe H, et al. Diffusion-weighted magnetic resonance imaging in infants with periventricular leukomalacia. Neuropediatrics 2008; 39(4): 233-238
Kono K, Okano Y, Nakayama K, et al. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 2005; 236(2): 630-636
Leuzzi V, Tosetti M, Montanaro D, et al. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MR1 and magnetic resonance spectroscopy (1H MRS) study. J Inherit Metab Dis 2007; 30(2): 209-216
De Marcos FA, Ghizoni E, Kobayashi E, et al. Cerebellar volume and long-term use of phenytoin. Seizure 2003; 12(5): 312-315
Lee SK, Mori S, Kim DJ, et al. Diffusion tensor MRI and fiber tractography of cerebellar atrophy in phenytoin users. Epilepsia 2003; 44(12): 1536-1540
Twardowschy CA, Wemeck LC, Scola RH, et al. The role of CYP2C9 polymorphisms in phenytoin-related cerebellar atrophy. Seizure 2013; 22(3): 194-197
Hwang JH, Egnaczyk CF, Ballard E, et al. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 1998; 19(3): 535-540
Kumar AJ, Leeds NE, Kumar VA, et al. Magnetic resonance imaging features of pilocytic astrocytoma of the brain mimicking high-grade gliomas. J Comput Assist Tomogr 2010; 34(4): 601-611
Plaza MJ, Borja MJ, Altman N, Saigal C. Conventional and advanced MRI features of pediatric intracranial tumors: posterior fossa and suprasellar tumors. AJR Am J Roentgenol 2013; 200(5): 1115-1124
Scheithauer BW, Hawkins C, Tihan T, et al. Pilocytic astrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 14-21
Arslanoglu A, Cirak B, Horska A, et al. MR imaging characteristics of pilomyxoid astrocytomas. AJNR Am J Neuroradiol 2003; 24(9): 1906-1908
Lee IH, Kim JH, Suh YL, et al. Imaging characteristics of pilomyxoid astrocytomas in comparison with pilocytic astrocytomas. Eur J Radiol 2011; 79(2): 311-316
Linscott LL, Osborn AC, Blaser S, et al. Pilomyxoid astrocytoma: expanding the imaging spectrum. AJNR Am J Neuroradiol 2008; 29(10): 1861-1866
Al-Holou WN, Maher CO, Muraszko KM, Carton HJL. The natural history of pineal cysts in children and young adults. J Neurosurg Pediatr 2010; 5(2): 162-166
Engel U, Gottschalk S, Niehaus L, et al. Cystic lesions of the pineal region - MRI and pathology. Neuroradiology 2000; 42(6): 399-402
Kahilogullari G, Massimi L, Di Rocco C. Pineal cysts in children: case-based update. Childs Nerv Syst 2013; 29(5): 753-760
Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol 2004:25(3^1): 177-195
Sapede D, Cau E. The pineal gland from development to function. CurrTop Dev Biol 2013; 106: 171-215
Nakazato Y, Jouvet A, Scheithauer BW. Pineal parenchymal tumour of intermediate differentiation. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 124-125
Fang AS, Meyers SP. Magnetic resonance imaging of pineal region tumours. Insights Imaging 2013; 4(3): 369-382
Knierim DS, Yamada S. Pineal tumors and associated lesions: the effect of ethnicity on tumor type and treatment. Pediatr Neurosurg 2003; 38(6): 307-323
Smith AB, Rushing EJ, Smirniotopoulos JG. From the archives of the AFIP: lesions of the pineal region: radiologic-pathologic correlation. Radiographics 2010; 30(7): 2001-2020
Tien RD, Barkovich AJ, Edwards MSB. MR imaging of pineal tumors. AJR Am J Roentgenol 1990; 155(1): 143-151
Zee CS, Segall H, Apuzzo M, et al. MR imaging of pineal region neoplasms. J Comput Assist Tomogr 1991; 15(1): 56-63
Fang AS, Meyers SP. Magnetic resonance imaging of pineal region tumours. Insights Imaging 2013; 4(3): 369-382
Jouvet A, Nakazato Y, Scheithauer BW, Paulus W. Papillary tumour of the pineal region. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 128-129
Nakazato Y, Jouvet A, Scheithauer BW. Pineocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 122-123
Nakazato Y, Jouvet A, Scheithauer BW. Pineal parenchymal tumour of intermediate differentiation. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 124-125
Nakazato Y, Jouvet A, Scheithauer BW. Pineoblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 126-127
Rosenblum MK, Nakazato Y, Matsutani M. CNS germ cell tumours - germinoma; mature teratoma; immature teratoma; teratoma with malignant transformation; yolk sac tumour (endodermal sinus tumour); embryonal carcinoma; choriocarcinoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 198-220
Smith AB, Rushing EJ, Smimiotopoulos JG. From the archives of the AFIP: lesions of the pineal region: radiologic-pathologic correlation. Radiographics 2010; 30(7): 2001-2020
Nakazato Y, Jouvet A, Scheithauer BW. Pineoblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 126-127
Nakamura M, Saeki N, Iwadate Y, et al. Neuroradiological characteristics of pineocytoma and pineoblastoma. Neuroradiology 2000; 42(7): 509-514
Deshmukh VR, Smith KA, Rekate HL, et al. Diagnosis and management of pineocytomas. Neurosurgery 2004; 55(2): 349-355, discussion 355-357
Nakazato Y, Jouvet A, Scheithauer BW. Pineocytoma. In: Louis DN, Ohgaki H, Wiestler OD. Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 122-123
Covington MF, Chin SS, Osborn AG. Pituicytoma, spindle cell oncocytoma, and granular cell tumor: clarification and meta-analysis of the world literature since 1893. AJNR Am J Neuroradiol 2011; 32(11): 2067-2072
Hammoud DA, Munter FM, Brat DJ, Pomper MG. Magnetic resonance imaging features of pituicytomas: analysis of 10 cases. J Comput Assist Tomogr 2010; 34(5): 757-761
Ulm AJ, Yachnis AT, Brat DJ, Rhoton AL Jr. Pituicytoma: report of two cases and clues regarding histogenesis. Neurosurgery 2004; 54(3): 753-757, discussion 757-758
Wesseling P, Brat DJ, Fuller GN. Pituicytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 243-244
Boellis A, di Napoli A, Romano A, Bozzao A. Pituitary apoplexy: an update on clinical and imaging features. Insights Imaging 2014; 5(6): 753-762
Murad-Kejbou S, Eggenberger E. Pituitary apoplexy: evaluation, management, and prognosis. Curr Opin Ophthalmol 2009; 20(6): 456-461
Aquilina K, Boop FA. Nonneoplastic enlargement of the pituitary gland in children. J Neurosurg Pediatr 2011; 7(5): 510-515
Ouyang T, Rothfus WE, Ng JM, Challinor SM. Imaging of the pituitary. Radiol Clin North Am 2011; 49(3): 549-571, vii
Rennert J, Doerfler A. Imaging of sellar and parasellar lesions. Clin Neurol Neurosurg 2007; 109(2): 111-124
Rumboldt Z. Pituitary adenomas. Top Magn Reson Imaging 2005; 16(4): 277-288
Crespo-Rodr?guez AM, Smimiotopoulos JC, Rushing EJMR. MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology 2007; 49(4): 307-315
Ciannini C, Paulus W, Louis DN, Liberski P. Pleomorphic xanthoastrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 22-24
Yu S, He L, Zhuang X, Luo B. Pleomorphic xanthoastrocytoma: MR imaging findings in 19 patients. Acta Radiol 2011; 52(2): 223-228
Barkovich AJ. MRI analysis of sulcation morphology in polymicrogyria. Epilepsia 2010; 51(Suppl 1): 17-22
Moinuddin A, McKinstry RC, Martin KA, Neil JJ. Intracranial hemorrhage progressing to porencephaly as a result of congenitally acquired cytomegalovirus infection - an illustrative report. Prenat Diagn 2003; 23(10): 797-800
Kulak W, Sobaniec W, Kubas B. et al. Spastic cerebral palsy: clinical magnetic resonance imaging correlation of 129 children. J Child Neurol 2007; 22( 1): 8-14
Duning Ò, Warnecke Ò, Mohammadi S, et al. Pattern and progression of white-matter changes in a case of posterior cortical atrophy using diffusion tensor imaging. J Neurol Neurosurg Psychiatry 2009; 80(4): 432-436
Giovagnoli AR, Aresi A, Reati F, et al. The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia. Neurol Sci 2009; 30(2): 123-131
McMonagle P, Deering F, Berliner Y, Kertesz A. The cognitive profile of posterior cortical atrophy. Neurology 2006; 66(3): 331-338
Migliaccio R, Agosta F, Rascovsky K, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology 2009; 73(19): 1571-1578
R?zsa A, Szilv?ssy 1, Kov?cs Ê, et al. [Posterior cortical atrophy (Benson-syndrome)]. Ideggyogy Sz 2010; 63(1-2): 45-47
Schmidtke K, Hull M, Talazko J. Posterior cortical atrophy: variant of Alzheimer’s disease? A case series with PET findings. J Neurol 2005; 252(1): 27-35
Pantel J, Schroder J. [Posterior cortical atrophy - a new dementia syndrome or a form of Alzheimer’s disease?]. Fortschr Neurol Psychiatr 1996; 64(12): 492-508
Whitwell JL, Jack CR Jr, Kantarci K, et al. Imaging correlates of posterior cortical atrophy. Neurobiol Aging 2007; 28(7): 1051-1061
Chapman Ò, Mahalingam S, Ishak GE, et al. Diagnostic imaging of posterior fossa anomalies in the fetus and neonate: part 2, Posterior fossa disorders. Clin Imaging 2015; 39(2): 167-175
Brennan ÊÑ, Lowe LH, Yeaney GA. Pediatric central nervous system posttransplant lymphoproliferative disorder. AJNR Am J Neuroradiol 2005; 26(7): 1695-1697
Cavaliere R, Petroni G, Lopes MB, Schiff D; International Primary Central Nervous System Lymphoma Collaborative Group. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 2010; 116(4): 863-870
Maecker B, Jack T, Zimmermann M, et al. CNS or bone marrow involvement as risk factors for poor survival in posttransplantation lymphoproliferative disorders in children after solid organ transplantation. J Clin Oncol 2007; 25(31): 4902-4908
Traum AZ, Rodig NM, Pilichowska ME, Somers MJ. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients. Pediatr Transplant 2006; 10(4): 505-512
Isaacs H. Fetal brain tumors: a review of 154 cases. Am J Perinatol 2009; 26(6): 453-466
McLendon RE, Judkins AR, Eberhart CG, et al. Central nervous system primitive neuroectodermal tumours. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 141-146
Mehrotra N, Shamji MF, Vassilyadi M, Ventureyra EC. Intracranial tumors in first year of life: the CHEO experience. Childs Nerv Syst 2009; 25(12): 1563-1569
Price SJ, Green HAL, Dean AF, et al. Correlation of MR relative cerebral blood volume measurements with cellular density and proliferation in high-grade gliomas: an image-guided biopsy study. AJNR Am J Neuroradiol 2011; 32(3): 501-506
Talbott SD, Plato BM, Sattenberg RJ, et al. Cortical restricted diffusion as the predominant MRI finding in sporadic Creutzfeldt-Jakob disease. Acta Radiol 2011; 52(3): 336-339
Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 2011; 76(20): 1711-1719
Young GS, Geschwind Ml), Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005; 26(6): 1551-1562
Gheuens S, Smith DR, Wang X, et al. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology 2012; 78( 18): 1390-1393
Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, et al. Update on PML and PML-1RIS occurring in multiple sclerosis patients treated with natalizumab. J Neuropathol Exp Neurol 2012; 71 (7): 604-617
Sahraian MA, Radue EW, Eshaghi A, et al. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol 2012; 19(8): 1060-1069
Massey LA, Micallef C, Paviour DC, et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012; 27(14): 1754-1762
Sitburana O, Ondo WG. Brain magnetic resonance imaging (MRI) in parkinsonian disorders. Parkinsonism Relat Disord 2009; 15(3): 165-174
Bergman AJIW, Van der Knaap MS, Smeitink JAM, et al. Magnetic resonance imaging and spectroscopy of the brain in propionic acidemia: clinical and biochemical considerations. Pediatr Res 1996; 40(3): 404^09
Brismar J, Ozand PT. CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. AJNR Am J Neuroradiol 1994; 15(8): 1459-1473
Chemelli AP, Schocke M, Sperl W, et al. Magnetic resonance spectroscopy (MRS) in five patients with treated propionic acidemia. J Magn Reson Imaging 2000; 11(6): 596-600
Nyhan WL, Bay C, Beyer EW, Mazi M. Neurologic non-metabolic presentation of propionic acidemia. Arch Neurol 1999; 56(9): 1143-1147
Bastos H, da Silva PFS, de Albuquerque MA, et al. Proteus syndrome associated with hemimegalencephaly and Ohtahara syndrome: report of two cases. Seizure 2008; 17(4): 378-382
Cohen MM Jr. Proteus syndrome review: molecular, clinical, and pathologic features. Clin Genet 2014; 85(2): 111-119
Jamis-Dow CA, Turner J, Biesecker LG, Choyke PL. Radiologic manifestations of Proteus syndrome. Radiographics 2004; 24(4): 1051-1068
Kaduthodil MJ, Prasad DS, Lowe AS, et al. Imaging manifestations in Proteus syndrome: an unusual multisystem developmental disorder. Br J Radiol 2012; 85(1017): e793-e799
Bobek-Billewicz Â, Stasik-Pres G, Majchrzak H, Zarudzki L. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol 2010; 48(2): 81-92
Cha J, Kim ST, Kim H-J, et al. Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression. Eur Radiol 2013; 23(3): 879-886
Fatterpekar CM, Calheigo D, Narayana A, et al. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum - use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 2012; 198(1): 19-26
Kim YH, Oh SW, Lim YJ, et al. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 1 IC-methionine PET and perfusion MRI. Clin Neurol Neurosurg 2010; 112(9): 758-765
Mitsuya K, Nakasu Y, Horiguchi S, et al. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 2010; 99(1): 81-88
Siu A, Wind J J, lorgulescu JB, et al. Radiation necrosis following treatment of high grade glioma - a review of the literature and current understanding. Acta Neurochir (Wien) 2012; 154(2): 191-201, discussion 201
Vidiri A, Guerrisi A, Pinzi V, et al. Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis? Eur J Radiol 2012; 81(6): 1246-1252
Olson HE, Lechpammer M, Prabhu SP, et al. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia 2013; 54( 10): 1753-1760
Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course. AJNR Am J Neuroradiol 2015; 36(8): 1392-1399
Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible cerebral vasoconstriction syndrome, part 2: diagnostic work-up, imaging evaluation, and differential diagnosis. AJNR Am J Neuroradiol 2015; 36(9): 1580-1588
Akgoz A, Mukundan S, Lee TC. Imaging of rickettsial, spirochetal, and parasitic infections. Neuroimaging Clin N Am 2012; 22(4): 633-657
Crapp S, Harrar D, Strother M, et al. Rocky Mountain spotted fever: «starry sky» appearance with diffusion-weighted imaging in a child. Pediatr Radiol 2012; 42(4): 499-502
Mailer VG, Agarwal AK, ChoudharyAK. Diffusion imaging findings in Rocky Mountain spotted fever encephalitis: a case report. Emerg Radiol 2012; 19(1): 79-81
Lou X, Chen ZY, Wang FL, Ma L. MR findings of Rosai-Dorfman disease in sellar and suprasellar region. Eur J Radiol 2012; 81(6): 1231-1237
Kara S, Sherr EH, Barkovich AJ. Dilated perivascular spaces: an informative radiologic finding in Sanfilippo syndrome type A. Pediatr Neurol 2008; 38(5): 363-366
Zafeiriou DI, Sawopoulou-Augoustidou PA, Sewell A, et al. Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo’s syndrome B). Brain Dev 2001; 23(6): 385-389
Chatzikonstantinou A, Gass A, Forster A, et al. Features of acute DW1 abnormalities related to status epilepticus. Epilepsy Res 2011; 97(1-2): 45-51
Forster A, Griebe M, Gass A, et al. Diffusion-weighted imaging for the differential diagnosis of disorders affecting the hippocampus. Cerebrovasc Dis 2012; 33(2): 104-115
Hakami T, McIntosh A, Todaro M, et al. MRI-identified pathology in adults with new-onset seizures. Neurology 2013; 81(10): 920-927
Kato T, Okumura A, Hayakawa F, et al. Transient reduced diffusion in the cortex in a child with prolonged febrile seizures. Brain Dev 2012; 34(9): 773-775
Kim JA, Chung JI, Yoon PH, et al. Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging. AJNR Am J Neuroradiol 2001 ; 22(6): 1149-1160
Milligan TA, Zamani A, Bromfield E. Frequency and patterns of MRI abnormalities due to status epilepticus. Seizure 2009; 18(2): 104-108
Stanescu L, Ishak GE, Khanna PC, et al. FDG PET of the brain in pediatric patients: imaging spectrum with MR imaging correlation. Radiographics 2013; 33(5): 1279-1303
Urbach H. Imaging of the epilepsies. Eur Radiol 2005; 15(3): 494-500
Camargo ECS, Bacheschi LA, Massaro AR. Stroke in Latin America. Neuroimaging Clin N Am 2005; 15(2): 283-296, x
Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarremen-teria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35(3): 664-670
Idbaih A, Boukobza M, Crassard I, et al. MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images. Stroke 2006; 37(4): 991-995
Jonas Kimchi T, Lee SK, Agid R, et al. Cerebral sinovenous thrombosis in children. Neuroimaging Clin N Am 2007; 17(2): 239-244
Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 2006; 26(Suppl 1): S19-S41, discussion S42-S43
Leach JL, Strub WM, Gaskill-Shipley MF. Cerebral venous thrombus signal intensity and susceptibility effects on gradient recalled-echo MR imaging. AJNR Am J Neuroradiol 2007; 28(5): 940-945
Lin A, Foroozan R, Danesh-Meyer H V, et al. Occurrence of cerebral venous sinus thrombosis in patients with presumed idiopathic intracranial hypertension. Ophthalmology 2006; 113(12): 2281-2284
Poon CS, Chang Ja-Kwei, Swamkar A, et al. Radiologic diagnosis of central venous thrombosis: pictorial review. AJR Am J Roentgenol 2007; 189: S64-S75
Ratai EM, Gonzalez RG. Magnetic resonance spectroscopy and the biochemical basis of neurologic disease. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. 4th ed. Lippincott Williams & Wilkins, 2009: 1836-1870
Rodallec MH, Krainik A, Feydy A, et al. Cerebral venous thrombosis and multidetector CT angiography: tips and tricks. Radiographics 2006; 26(Suppl 1 ): S5-S18, discussion S42-S43
Sagduyu A, Sirin Í, Mulayim S, et al. Cerebral cortical and deep venous thrombosis without sinus thrombosis: clinical MRl correlates. Acta Neurol Scand 2006; 114(4): 254-260
Wasay M, Bakshi R, Bobustuc C, et al. Cerebral venous thrombosis: analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis 2008; 17(2): 49-54
deVeber Ñ, Andrew Ì, Adams Ñ, et al; Canadian Pediatric Ischemic Stroke Study Croup. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345(6): 417-423
Dlamini N, Billinghurst L, Kirkham FJ. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am 2010; 21(3): 511-527
Nwosu ME, Williams LS, Edwards-Brown M, et al. Neonatal sinovenous thrombosis: presentation and association with imaging. Pediatr Neurol 2008; 39(3): 155-161
Sebire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128(Pt 3): 477-489
Standridge SM, O’Brien SH. Idiopathic intracranial hypertension in a pediatric population: a retrospective analysis of the initial imaging evaluation. J Child Neurol 2008; 23(11): 1308-1311
Wasay M, Dai Al, Ansari M, et al. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol 2008; 23(1): 26-31
Wu YW, Hamrick SEG, Miller SP, et al. Intraventricular hemorrhage in term neonates caused by sinovenous thrombosis. Ann Neurol 2003; 54(1): 123-126
Luyendijk J, Steens SCA, Ouwendijk WJN, et al. Neuropsychiatry systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum 2011; 63(3): 722-732
Tektonidou MG, Varsou N, Kotoulas G, et al. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 2006; 166(20): 2278-2284
Valdes-Ferrer SI, Vega F, Cantu-Brito C, et al. Cerebral changes in SLE with or without antiphospholipid syndrome, a case-control MRI study. J Neuroimaging 2008; 18(1): 62-65
Zivadinov R, Shucard JL, Hussein S, et al. Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement. Lupus 2013; 22(7): 675-683 [Epub ahead of print]
Cloonan L, Fitzpatrick KM, Kanakis AS, et al. Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke. Atherosclerosis 2015; 240(1): 149-153
Conijn MMA, Kloppenborg RP, Algra A, et al; SMART Study Group. Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ART-erial disease-Magnetic Resonance (SMART-MR) study. Stroke 2011;42(11): 3105-3109
Erten-Lyons D, Woltjer R, Kaye J, et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology 2013; 81(11): 977-983
Horikoshi H, Kato Z, Masuno M, et al. Neuroradiologic findings in Sotos syndrome. J Child Neurol 2006; 21(7): 614-618
Leventopoulos G, Kitsiou-Tzeli S, Kritikos K, et al. A clinical study of Sotos syndrome patients with review of the literature. Pediatr Neurol 2009; 40(5): 357-364
Fuller GN, Scheithauer BW, Roncaroli F, Wesserling P. Spindle cell oncocytoma of the adenohypophysis. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 245-246
Mascalchi M. Spinocerebellar ataxias. Neurol Sci 2008; 29(Suppl 3): 311-313
Perlman SL. Spinocerebellar degenerations. Handb Clin Neurol 2011; 100: 113-140
Schulz JB, Borkert J, WolfS, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1,3 and 6. Neuroimage 2010; 49(1): 158-168
Seidel K, Siswanto S, Brunt ERP, et al. Brain pathology of spinocerebellar ataxias. Acta Neuropathol 2012; 124(1): 1-21
Clarke MJ, Foy AB, Wetjen N, Raffel C. Imaging characteristics and growth of subependymal giant cell astrocytomas. Neurosurg Focus 2006: 20(1): E5
Lopes MBS, Wiestler OD, Stemmer-Rachamimov AO, Sharma MC. Tuberous sclerosis complex and subependymal giant cell astrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 218-221
Chiechi MV, Smimiotopoulos JG, Jones RV. Intracranial subependymomas: CT and MR imaging features in 24 cases. AJR Am J Roentgenol 1995; 165(5): 1245-1250
Fujisawa H, Hasegawa M, Ueno M. Clinical features and management of five patients with supratentorial subependymoma. J Clin Neurosci 2010; 17(2): 201-204
Ragel ÂÒ, Osborn AG, Whang K, et al. Subependymomas: an analysis of clinical and imaging features. Neurosurgery 2006; 58(5): 881-890, discussion 881-890
McLendon RE, Schiffer D, Rosenblum MK, Wiestler OD. Subependymoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: IARC Press, 2007: 70-71
Kumar N. Superficial siderosis: associations and therapeutic implications. Arch Neurol 2007; 64(4): 491496
Kumar N, Fogelson JL, Morris JM, Pichelmann MA. Superficial siderosis should be included in the differential diagnosis of motor neuron disease. Neurologist 2012; 18(3): 139-145
Sydlowski SA, Cevette MJ, Shallop J. Superficial siderosis of the central nervous system: phenotype and implications for audiology and otology. Otol Neurotol 2011; 32(6): 900-908
Darwish BS, Fowler A, Ong M, et al. Intracranial syphilitic gumma resembling malignant brain tumour. J Clin Neurosci 2008; 15(3): 308-310
Hama K, Ishiguchi H, Tuji T, et al. Neurosyphilis with mesio-temporal magnetic resonance imaging abnormalities. Intern Med 2008; 47(20): 1813-1817
Soares-Fernandes JP, Ribeiro M, Mare R, et al. Diffusion-weighted magnetic resonance imaging findings in a patient with cerebral syphilitic gumma. J Comput Assist Tomogr 2007; 31(4): 592-594
Erbetta A, Salmaggi A, Sghirlanzoni A, et al. Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments. Neurol Sci 2008; 29(3): 131-137
Inaba H, Khan RB, Laningham FH, et al. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 2008; 19(1): 178-184
Serkova NJ, Christians U, Benet LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004; 4(2): 97-107
Hegde AN, Mohan S, Lath N, Lim CCT. Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus. Radiographics 2011; 31 (1): 5-30
Sharma P, Eesa M, Scott JN. Toxic and acquired metabolic encephalopathies: MR1 appearance. AJR Am J Roentgenol 2009; 193(3): 879-886
Iyer RS, Chaturvedi A, Pruthi S, et al. Medication neurotoxicity in children. Pediatr Radiol 2011; 41(11): 1455-1464
Patkar D, Narang J, Yanamandala R, et al. Central nervous system tuberculosis: pathophysiology and imaging findings. Neuroimaging Clin N Am 2012; 22(4): 677-705
Arulrajah S, Ertan C, Jordan L, et al. Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex. Neuroradiology 2009; 51(11): 781-786
Lopes MBS, WiestlerOD, Stercmer-Rachamimov AO, Sharma MC. Tuberous sclerosis complex and subependymal giant cell astrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Geneva: I ARC Press, 2007: 218-221
Michelozzi C, Di Leo C, Galli F, et al. Subependymal nodules and giant cell tumours in tuberous sclerosis complex patients: prevalence on MRI in relation to gene mutation. Childs Nerv Syst 2013; 29(2): 249-254
Piao C, Yu A, Li K, et al. Cerebral diffusion tensor imaging in tuberous sclerosis. Eur J Radiol 2009; 71(2): 249-252
Choi CC, Yoo HW. Localized proton MR spectroscopy in infants with urea cycle defect. AJNR Am J Neuroradiol 2001; 22(5): 834-837
Dlamini N, Billinghurst L, Kirkham FJ. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin NAm 2010; 21(3): 511-527
Hegde AN, Mohan S, Lath N, Lim CCT. Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus. Radiographics 2011; 31(1): 5-30
Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 2006; 26(Suppl 1): S19-S41, discussion S42-S43
De Simone T, Regna-Gladin C, Carriero MR, et al. Wal-lerian degeneration of the pontocerebellar fibers. AJNR Am J Neuroradiol 2005; 26(5): 1062-1065
Fitzek C, Fitzek S, Stoeter P. Bilateral Wallerian degeneration of the medial cerebellar peduncles after ponto-mesencephalic infarction. Eur J Radiol 2004; 49(3): 198-203
Kiiker W, Schmidt F, Heckl S, et al. Bilateral Wallerian degeneration of the middle cerebellar peduncles due to paramedian pontine infarction: MRI findings. Neuroradiology 2004; 46(11): 896-899
Liu X, Tian W, Li L, et al. Hyperintensity on diffusion weighted image along ipsilateral cortical spinal tract after cerebral ischemic stroke: a diffusion tensor analysis. Eur J Radiol 2012; 81(2): 292-297
Musson R, Romanowski C. Restricted diffusion in Wallerian degeneration of the middle cerebellar peduncles following pontine infarction. Pol J Radiol 2010; 75(4): 38—43
Puig J, Pedraza S, Blasco G, et al. Wallerian degeneration in the corticospinal tract evaluated by diffusion tensor imaging correlates with motor deficit 30 days after middle cerebral artery ischemic stroke. AJNR Am J Neuroradiol 2010; 31(7): 1324-1330
UchinoA, Sawada A, Takase Y, Kudo S. Symmetrical lesions of the middle cerebellar peduncle: MR imaging and differential diagnosis. Magn Reson Med Sci 2004; 3(3): 133-140
Uchino A, Yuzuriha T, Murakami M, et al. Magnetic resonance imaging of sequelae of central pontine myelinolysis in chronic alcohol abusers. Neuroradiology 2003; 45(12): 877-880
Bathla G, Hegde AN. MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adults. Clin Radiol 2013; 68(6): 545-554
Beh SC, Frohman TC, Frohman EM. Isolated mammillary body involvement on MRI in Wernicke’s encephalopathy. J Neurol Sci 2013; 334(1-2): 172-175
Elefante A, Puoti G, Senese R, et al. Non-alcoholic acute Wernicke’s encephalopathy: role of MRI in non typical cases. Eur J Radiol 2012; 81(12): 4099-4104
Zuccoli G, Santa Cruz D, Bertolini M, et al. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol 2009; 30(1): 171-176
Kim TJ, Kim IO, Kim WS, et al. MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol 2006:27(6): 1373-1378
King AD, Walshe JM, Kendall BE, et al. Cranial MR imaging in Wilson’s disease. AJR Am J Roentgenol 1996; 167(6): 1579-1584
Kitzberger R, Madl C, Ferenci P. Wilson disease. Metab Brain Dis 2005; 20(4): 295-302
Magalhaes ÀÑÀ, Caramelli P, Menezes JR, et al. Wilson’s disease: MRI with clinical correlation. Neuroradiology 1994; 36(2); 97-100
Rosencrantz R, Schilsky M. Wilson disease: pathogenesis and clinical considerations in diagnosis and treatment. Semin Liver Dis 2011; 31(3): 245-259
Thapa R, Ghosh A. «Face of the giant panda» sign in Wilson disease. Pediatr Radiol 2008; 38(12): 1355
van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, et al. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996; 198(2): 531-536
Youn J, Kim JS, Kim HT, et al. Characteristics of neurological Wilson’s disease without Kayser-Fleischer ring. J Neurol Sci 2012; 323(1-2): 183-186
Lee PR, Raymond GV. Child neurology: Zellweger syndrome. Neurology 2013; 80(20): e207-e210
van der Knaap MS, Wassmer E, WolfNI, et al. MRI as diagnostic tool in early-onset peroxisomal disorders. Neurology 2012; 78(17): 1304-1308
Weller S, Rosewich H, Gartner J. Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients. J Inherit Metab Dis 2008; 31(2): 270-280
